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THE CHEMISTRY OF THE FIBRINOGEN - FIBRIN CONVERSION 
I. RELATION TO BLOOD COAGULATION 
The formation of the fibrin clot is the culmination of 
a series of complex reactions involved in the process of blood 
coagulation. The major components of blood which are involved in 
coagulation are listed in Table I. Procoagulents are substances 
which bring about coagulation; anticoagulents are substances which 
prevent coagulation or dissolve the clot once it is formed. There 
are many proposed theories of blood coagulation (11), one of which 
is shown in Fig. I. There appears to be considerable disagreement 
on the role of the various factors involved and even on the nomen-
clature, as indicated by the variety of synonyms. However, it can 
be said that, ~ vivo, reactions take place which ultimately lead 
to the production of thrombin. When thrombin becomes available, 
it converts fibrinogen to fibrin to prevent hemorrhage. After 
bleeding has stopped, subsequent reactions eliminate thrombin and 
lyse the fibrin clot. While fibrinogen exists 1n normal blood, 
thrombin is present only as its inactive precursor, prothrombin. 
1 
2 
TABLE I 
COMPONENTS OF NORMAL HUMAN BLOOD CONCERNED WITH COAGULATION 
PROCOAGULANTS 
Fibrinogen 
Platelets 
Calcium 
Precursor of Serum prothromb1n 
Conversion accelerator 
Prothrombin 
Accelerator globulin 
Antihemophilic globul1n 
AHTICOAOULAN'fS 
Antithromb1n 
L1poprote1n Ant1thromboplastin 
Heparin cofactor 
Plasminogen 
3 
Platelets + Plasma Factor( s)l Thromboplastin 
flForeign Surface" 
Thromboplastin + Prothrombin 
+ 
Thrombin 
+ 
pro-SPCA4 Plasma AC-Globulin2 
! 
SPfA5 
~ 
Serum AC-Globulin3 
I 
Thrombin + Fibrinogen -----;~~ Fibrin 
+ 
Antithrombin(s) 
1 Heparin 
Metathrombin 
1 Platelets 
Fibrin Retraction 
Plasminogen + Plasmin 
Fibrin Lysis 
Synonyms: (1) 
(2) 
Antihemophilic Globulin; Thromboplastinogenj 
Thrombocytolysinj Plasma Thromboplastin. 
Thrombogen; Prothrombin Acceleratorj Labile Factor; 
Factor Vi Proaccelerinj Fraction "A"; Plasmakininj 
Prothrombokinase. 
(5) 
Factor VIi Accelerin. 
Precursor of Serum Prothrombin Conversion Acceler-
atorj Proconvertinj Co-factor Vj Co-thromboplastinj 
Factor VII; Thrombokinase. 
Serum Prothrombin Conversion Acceleratorj 
Convertin. 
Fig. I Modern scheme of blood coagulation (1). 
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The coagulation process therefore consists of 1) conversion of 
prothrombin to thrombin and 2) the subsequent action of thrombin 
on fibrinogen to produce fibrin. Under normal physiological con-
ditions the latter reaction starts as soon as a trace of thrombin 
is produced, that is, before the first reaction is complete. 
This thesis is concerned with a study of the kinetics 
of the thrombin - fibrinogen reaction carried out with isolated 
and purified thrombin and fibrinogen so that complications arising 
from the prothrombin to thrombin conversion are eliminated. 
II. THROMBIN 
The enzyme thrombin is not present in normal circulating 
blood. Instead, normal plasma contains the precursor prothrombin 
at a concentration of about '70 mg/l. (22); i.e. about 0.14;£ of the 
plasma proteins. Hence, any fractionation procedure designed to 
obtain purified prothrombin must permit the separation of this 
trace amount of enzyme precursor from large quantities of other 
plasma proteins. 
Prothrombin is generally obtained from bovine plasma by 
isoelectric precipitation, absorption on Mg(OH)2' elution, ammoni-
um sulfate fractionation and a second isoelectric precipitation 
(53). This can be followed by absorption of non-prothz'ombin mate-
rials on BaC03• Other methods depend on absorption of prothrombin 
5 
from plasma on BaS04, ammonium sulrate fractionation, isoelectric 
precipitation and Seitz filtration to remove factor VII (63). 
Modifications of these methods are now generally used in which the 
purified prothrombin is chromatographed to further "modify" the 
prothrombin. The word "modify" 1s used rather than purify because 
the thrombin obtained from aotivation of chromatographed prothrom-
bin is apparently difrerent rrom non-chromatographed prothrombin, 
and because the C-terminal amino acids of suoh prothrombins differ 
(52). Amberlite IRC-50 (XE-64) has been used for this chromato-
graphy (41) and the prothrombin obtained (termed "reSin" prothrom-
bin) has increased speoific aotivity due to the removal of mate-
rials whioh would later be absorved and eluted under the same oon-
ditions as thrombin. Diethylamino ethyl cellulose (DEAE) can also 
be used with apparently similar results to those obtained with 
IRC-50 (52). The preparations obtained from DEAE chromatography 
have been called uDEAE-prothrombin". 
~ !.!:!2 activation of prothrombin to give thrombin is 
far from being a simple prooess (Fig. I). It appears however that 
the enzymes(s) required for this process is part of the prothrom-
bin molecule (50) and that all prothrombin preparations contain 
some thrombin as such. Other blood factors increase both the rate 
and the degree of activation of prothrombin viz. ca++~ platelet 
factors, Ac-Olobulin, lipids, proconvertin, convertin and pOSSibly 
other substances (50,66). 
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!rzymatlc Properties of Thrombin 
There are close similarities between thrombin and 
trypsin in their action on synthetic substrates e.g. p-toluene-
sulfonyl-L-arginine methyl ester (TAMe), (56) lysine ethyl and 
methyl esters (41). Thrombin, like trypsin is inhibited by diiso-
propylfluorophosphate (DPP) and the amino acid sequence near the 
DFP binding site is identical for the two enzymes (19). This plus 
the fact that of the approximately 3000 peptide bonds in fibrino-
gen, those hydrolyzed by thrombin involve only arginine (see Fig. 
IV), leads to the conclusion that thrombin i8 specific for argi-
nine conta1ning bonds. 
The activity ot thrombin has traditionally been deter-
mined by ascertaining the time required for an aliquot to clot a 
standard solution of fibrinogen. In the clotting time assay, an 
aliquot whose thrombin activity is to be determined is mixed with 
a solution of fibrinogen. Two "clotting time" (tc ) end points 
have been usedj the time for gelation of a solut1on held quiescent 
after mixing, or the appearance ot compacted strands of fibrin 1n 
an agitated solution. An assay system containing fibrinogen as 
its only added collOid component was first used and a unit of 
thrombin was defined as that amount which produced a clot in 15 
seconds (61,65). When a pooled plasma was used as a reference 
standard, day to day variations in plasma prothrombin activity 
'7 
were observed. This variation was reduced by adding gum acacia to 
the mixture. Assay conditions were extensively re-examined (54) 
and a set of conditions was derived for temperature, pH, gum aca-
cia concentration and 10nic strength Which form the oasis for all 
current assay systems including those specified by the National 
Institutes of Health (40). The variation of clotting time with 
thrombin concentration using the above method is shown in Pig. 
XIII (Chapter Ill). This figure demonstrates that the relation 
between clotting time and thrombin concentration is non-linear. 
A more convenient method of thrombin assay is to measure 
the rate of hydrolysis of the synthetiC substrate p-tosyl L-argi-
nine methyl ester (TAMe) by the enzyme (56). The reaction cata-
lyzed is illustrated in Fig. II. This hydrolysis has been follow-
ed by direct potentiometric titration (13,49). The unit adopted 
when using this method is that amount of thrombin which will hy-
drolyse 0.1 ~ole TAMe per minute from 1 ml. of 0.01 ! TAMe at 
pH 8 in 0.15 ! KCl at 25°C. A modification ot' this method is 
based on the fact that p-tosyl L-arginine has a higher absorbance 
at 247 mu. than does TAMe (23). The rate of hydrolysis can thus 
be followed by measuring the rate of increase in absorbance at 
247 millimicrons (mu). Possible objections to the use of TAMe as 
a substrate for assay purposes are that it may not be applicable 
to the determination ot' thrombin purity Since other enzymes hy-
drolyse TAMe (e.g. trypSin, chymotrYPSin) and that the ratio of 
I~ 
C=Na; 
I 
}fH 
I 
I~ 
CH2 Thrombin 
I + H20 -
I~ 
CH-NH-S02C6H4CH3 
I COOCH3 
p-Tolueneaulfonyl-L-arginine 
methyl eater 
(TAMe) 
8 
p-Tolueneaulfonyl-L-arginine 
(TA) 
Fig. II. Bnzymatic hydrolyaia of TAMe by thrombin (56). 
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esterase activity to clotting activity has been reported to vary 
for different thrombin preparations (51,53). 
III. FIBRINOGEN 
Fibrinogen is one of the constituents of blood plasma. 
It is present at a concentration of about 2 gil and represents 
about 4% of the plasma proteins (8). From the point of view of 
its solubility properties, fibrinogen may be regarded as a globu-
lin since it is insoluble in water but soluble in dilute salt 
solution. 
Fibrinogen can be obtained from plasma on a large scale 
by ethanol fractionation. Fibrinogen is precipitated at low tem-
peratures (Cohn fraction 1) by bringing the concentration of 
ethanol to 8~ after removal of prothrombin and the precursor of 
serum prothrombin conversion accelerator by adsorption on BaS04 
(8,25). The fibrinogen can then be refractionated to remove in-
soluble globulin impurities by control of pH, ionic strength and 
temperature, followed by precipitation of fibrinogen from the 
supernatant by means of ammonium sulfate (25). 
Purified fibrinogen solutions, when acted on by thrombIn 
usually contain some material that can not be transformed into a 
fibrin clot. Such material is known as the non-clottable fract10n 
(HC) and could be eIther non-fibrinogen proteIn, denatured fibrin-
'fABLE II 
VALUES OF PHYSICAL CHEMICAL PROPERTIES OF HUMAN 
AND BOVINE FIBRINOGEN (48) 
Property 
Intrinsic viscosity, 100 ml./g. 
Part1al specific volume, V, ml./g. 
Sedimentation constant, S20,w' Svedberg units 
Translational diffusion coefficient, D2o,w' (Fick units) 
-1 Rotational d1ffus1on coefficient, 820,w,sec 
Refractive increment, dn/dc, at 436 ~, ml./g. 
Principal refractive indices, nl ,n2,n3 at 544 mu. 
Molecular weight, M, g./mole. 
Molecular length, A. 
Axial rat10 
Value 
0.25 
0.'71-0.'12 
'{. (-7.9 
2.0 
40,000 
0.19'( 
1.64,1.69,1.69 
330,000-340,000 
500-600 
5 (prolate ellipsoid) 
I-' 
o 
11 
ogen, fibrinopeptides or fibrin monomer and polymers in eQul1ibri-
um with clot. The per cent non-clottable is usually taken as 
being a measure of fibrinogen purity and is determlned by clotting 
a fibrinogen solution with thrombin, removing the clot and meas-
urlng the absorbance (at 280 m~) of the supernatant. 
Except for the most recent observatlons, most physical 
chemical studies have been carried out on fibrinogen preparations 
which were quite impure by the clottability criterion. Edsall 
(12) has discussed some of the problems involved in the interpre-
tation of the physical chemlcal parameters of fibrinogen and 
Scheraga and Laskowski (48) have reported a set of parameters 
which they regard as being the best values. These are shown in 
Table II. Human and bovine flbrinogen appear indistinguishable by 
most physical chemical criteria, the only exoeption being eleotro-
phoretio mobility. The electrophoretio mobility of bovine fibrin-
ogen ls slightly higher than human fibrinogen (9) this result 
being compatible with the N-terminal amino acid oomposition shown 
in Fig. III. Although fibrinogen and fibrin (as fibrin monomer) 
are indistinguishable with respeot to viscosity, light scattering, 
sedimentation behaviour and flow birefringence (48), they are 
dlfferent chemically as will be shown in section IV. 
12 
IV. GENERAL ASPECTS OF THE THROMBIN - FIBRINOGEN REACTION 
When thrombin is added to fibrinogen in an appropriate 
buffer, the fibrinogen solution i8 oonverted to a fairly rigid 
gel, the fibrin olot. During the oourse of the reaotion the ini-
tially olear reaotion mixture inOI'eases in turbicii ty as shown in 
Fig. X (Chapter III). The olot also beoomes rigid after a time 
and increases as the reaotion proceeds, paralleling the lncrease 
in turbidity. From Fig. X it ls seen that the turbidity inoreases 
sharply at the clotting time, tc. Other properties of the solu-
tion, such as the Viscosity or the amount of reooverable fibrin, 
show a marked increase at tc. The value of tc is found to be 
markedly dependent on pH and ionic strength. The clotting time 
becomes infinite (i.e. no clot forms) at pH's lower than 5 and 
greater than 10 and attains very low values (i.e. rapid clot for-
mation) in the neutral pH region. It has been shown also that at 
a given pH, tc is increased by an increase in ionic strength (58). 
Thrombin causes an initial alteration in the fibrinogen 
molecule without changing its hydrodynamic properties (25). When 
thrombin was incubated with bovine fibrinogen at pH 4.85, no clot-
ting occured. However, when the solution was brought to neutral 
pH, the value of tc was much lower than for a corresponding mix-
ture which had not been exposed to the low pH treatment. Further-
more, the olotting time of the reneutrallzed mixture deoreased 
13 
with increasing incubation time at pH 4.85. It was thus concluded 
that at pH 4.85, fibrinogen (F) was converted to another species, 
fibrin monomer (f) and that the further conversion of f to a fi-
brin clot was inhibited at pH 4.85. The species F and f were in-
distinguishable by viscosity and sed1mentation experiments. 
While fibrinogen and fibrin show similar hydrodynamic 
behaviour and presumably therefore have the same size and shape, 
they do have different electrophoretic mobilities (38). The dif-
ference in electrophoretic mobility indicates that fibrinogen and 
fibrin monomer may differ in amino acid composition and/or net 
charge and is compatible with the findings that the N-terminal 
residues of bovine fibrinogen and fibrin (and hence presumably f) 
differ in that fibrinogen has N-terminal tyrosyl and glutamyl res-
idues whereas fibrin has instead tyrosyl and glycyl residues (3). 
This difference was attributed to the liberation of peptide mate-
rial (fibrinopeptide) from fibrinogen during the course of the 
clotting process. The fibrinopeptide was later isolated from the 
supernatant solutions of fibrin clots and found to contain the N-
terminal glutsmyl residue missing from fibrin (5,34,35). 
Fibr1nopeptide 1s not an artifact of the method~ nor is 
it originally present as such 1n either fibrinogen or thrombin. 
The amount of non-protein nitrogen present in the clot supernatant 
has been found to rise sharply with the time of incubation of 
thrombin and fibrinogen, and then level off at about 3% of the 
14 
total nitrogen present (35). The initial rapid rate of production 
of non-protein nitrogen parallels the rate of clotting and the 
asymptotiC level of the curve .. maintained for more than 18 hOIJrs, 
indicates that the production of non-protein nitrogen :.i.s not due 
to clot breakdown (fibrinolysis);, but is a characteristic featllre 
of the enzymatic action of thrombin on fiox'lnogen. The ~roductio 
of non-protein nitrogen does not stop at tc. The development of 
non-protein nitrogen has also been demonstrated in solvents (0.3 
M KCl pH 5, 1 M NaDr pH 5.3, 2 M NaDr at pH 5.7) where no poly-
- - -
merizatlon occurs thus eliminating the possibility that the pep-
tide 1s aplit off during the subsequent polymerization of f (29). 
The overall first step in the fibrinogen - fibrin con-
version can be represented by 
p--~~r + P 1. 
Where F • fibrinogen, T • thrombin, f • flbrin 
mono.er and P • flbrinopeptide. 
The subsequent fate of f was studied by following the 
ultracentrifuge patterns of thrombin-fibrinogen-hexamethylene 
glycol mixtures with time (59). Hexamethylene glycol preventa th 
formation of the fibr1n clot. Such mixturea in the ultracentri-
fuge Showed the presence of a fast (S20,w = 25) and a slow 
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(~o,w • 8) component. The slow component was indistinguishable 
from fibrinogen and the fast component was identified aa interme-
diate polymers. As the reaction time in the glycol increased, the 
relative area of the fast and slow peaks increased and decreased 
respectively, indicating the conversion of fibrinogen into inter-
mediate polymers. Other inh1b1tors, auch as 0.5 ! L1Br, 1 ! KaBr 
and 1 ! urea, can be used to demonstrate the exiatence ot interme-
diate polymers in thrombin - fibrinogen mixtures or in fibrin so-
lutions (10). 
The particle length of the polymers just prior to the 
gel point is dependent on pH and it appears as though there is a 
significant number of relatively long particles before the gel 
point between pH 6 and 10 and ahorter ones outSide this range. 
Since the sedimentation constants of elongated polymers ot con-
stant width would not be very dependent on the length and hence 
not separable in the ultracentrifu&e, the two peaks present in the 
ultracentrifuge pattern are indicative ot equilibria between vari-
ous n-mers, rather than of two distinct species. 
Plow birefringence data indicate that the intermediate 
polymers dissociate on dilution, showing that the reaction in 
which intermediate polymera are formed from fibrin monomer is re-
veraible (45). This step may be written as 
nf ---I .... f 
n 2. 
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If it is recognized that intermediate polymers must be 
bound into the fibrin network, a final step can be written as 
m(tn ) _ b fibrin 
An equilibrium is indicated here because it has been shown (31) 
that the solubilit~ of fibrin clots increases with increasing 
temperature. 
3. 
The reaction scheme for the fibrinogen - fibrin conver-
sion can be summarized as 
Step 
Step 
Step 
1. 
2. 
proteol~sis 
polymerization 
clotting 
T 
"--·~f+ P 
nf --·~fn 4. 
m(fn ) .. Fibrin 
The above individual steps will now be disoussed ind1-
vidually. 
V. STEP l: PROTBOLYSIS 
The proteolysis step involves the formation ot fibrin 
monomer from fibrinogen with the simultaneous release of fibrino-
peptide material. Bettleheim (4) round that this fibrinopeptide 
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material can be separated into two fractions, peptides A and B, 
veptide A travelling faster toward the anode than peptide B on pa-
per electrophoresis at pH 4.15. Peptide A contains N-terminal 
glutamic acid whereas peptide B contains no detectable X-terminal 
group_ 
The stoich10metry of the release of peptj.des A and B is 
shown in Fig. III. For example, bovine fibrinogen contains six 
chains, two each having N-terminal glutamic acid and tyrosine re-
spectively and two chains with no detectable X-terminal group, 
this being due to the fact that the X-terminal group of peptide B 
is N-acetylated (see Fig. IV). Papain and snake venom enzyme 
split two bonds on bovine fibrinogen with the release of only two 
moles ot peptide A and produce a clottable material ('7), whereas 
thrombin can split 4 bonds with the release of two moles of pep-
tide A and two moles ot peptide B. In view ot this it seems as 
though the release ot peptide B is not required tor clotting and 
may be an extraneous action ot thrombin not pertinent to the clot-
ting process. This is obviously an important point and needs to 
be answered. 
The oom~lete amino acid sequence of peptide. A and B 
are shown 1n Fig. IV (6,18). Both peptides contain C-terminal ar-
ginine, consistent with the known specificity of thrombin, showins 
that arginine - glycine bonds are hydrolysed in step 1. Peptide 
A contains no tyrosine and peptide B contains one molecule as 
Ox Pig HOlD 0 
0 Ala 
0 Ala 
Glu Ala 
Glu Ala 
Tyr Tyr 
171" 'l'yr 
Gly 
Oly 
Gly 
Gly 
Tyr 
Tyr 
FIBRINOGEN 
0 
0 
Ala 
Ala 
Tyr 
'fyr 
Sheep 
Goat 
Gly 
Gly 
Ala 
Ala 
Tyr 
Tyr 
0 
0 
(Uy 
Gly 
Tyr 
Tyr 
FIBRIN 
Dog Horse 
0 0 
0 0 
Thr Thr 
'fhr Thr 
Tyr Tyr 
Tyr Tyr 
Thrombin 
~ 
Papain or 
---------~ 
Snake Venom Enzyme 
Fig. III. N-Terminal amino acids 1n fibrinogen and fibrin from 
d1fferent species. The number of chains correspond to 
a molecular weight of 350,000 except for horse fibrin-
ogen, where the molecular weight ia 500,000. The cir-
clea indicate chains with no detectable N-termlnal 
group a ('7). 
Peptide A. 
Glu.Asp.Gly. Ser.Aap.Pro. Pro. Ser.Gly.Aap. Phe.Leu.Thr.Glu .Oly.Oly.Gly.Val.Ar&. 
1 2 3 4 5 6 1 8 9 10 11 12 13 14 15 16 17 18 19 
Peptide B. 
T·acetYl. 104 
Thr.01u.Phe.Pro.Aap.!7r.Asp.Olu.01y.Glu.Asp.Asp.Arg.Pro.Lys.Val.G1y.Leu.Gly.A1a.Arg. 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 11 18 19 20 21 
Pig. IV Amino acid sequenoes of peptide. A and B. (6,17). 
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tyrosine-O-sulphate. Sinee fibrinogen concentrations are usually 
determined from absorbance measurements at 280 lD)J, the clottabil-
ity (Chapter III) in terms of absorbance measurements should be 
very close to 100%, because tyrosine-O-sulphate has relatively 
little absorbance at 28O~. (4). 
The acidity of peptides A and B, due to the excess of 
free oarboxyl over basic groups, is compatible with the electro-
phoresis experiments quoted earlier (38). 
VI. S'l'BP 2 
As mentioned earlier, sedimentation studies carried out 
using hexamethylene glycol to inhibit step 3 indicated that the 
intermediate polymers were highly asymmetrical end to end aggre-
gates (59). Other workers (2,10,17), have shown that the inter-
mediate polymers were polydispersed with a general size range of 
o 
3,000 to 6,000 A. While there is heterogeneity in length, the 
width of the polymers seems to be fairly uniform and about twioe 
that of the monomer, with the molecules aligned by a staggered 
overlapping. 
In view of the polydisperse character of the intermedi-
ate polymers, step 2 should be written as a system ot many fairly 
rapid reversible equilibria (10): 
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fl + f l -- • f2 
f2 i- f l oc 
.. f3 
• • 
• • 5. 
• • • 
f
n
_l fl '" 
.. fn 
This scheme does not neceaaarily imply that polymeriza-
tion takes place by addition of monomers only, but that the equi-
librium state can be descr1bed in terms of the equ1librium con-
stants corresponding to the above reactions, where 
6. 
and n) 1 
The weight average degree of polymerizat10n (~)w is ob-
viously a function of In. Donnelly, et al, (10) studied the ef-
fect of the concentration of protein c (g/IOO ml) on (~)w using 
li~ht scattering measurements. Pig. V shows the results of these 
experiments. It was found that the equilibrium constants Kn in-
creased very slightly from K2 to K7 and then began to increase 
rapidly. Because of the small variation of (Dr)w with c at low c, 
large errors are introduced and the values of the equilibrium 
20 
(OPt. 
w 
10 
22 
0.1 0.2 0.3 
Protein (g/IOO mi.) 
2 li&_ V. Plot of (~)w against protein oonoentration (10). 
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constants could not be obtalned. The tact that these equilibrium 
constants are unequal can be established by the process ot reduc-
tio ad absurdum. It it is assumed that all the equilibrium con-
stants are equal, then the follow1ng relation can be derived trom 
definitions of In and (Dr)w. 
+ 1 '7. (»1)2 :: W 
4 Xc 
M 
where M is the molecular weight of tibrin and X • In for ever" 
n. 
Since the data ot Pig. V do not even approximate the 
straight line that would be expected trom a plot of (%SF): va c, it 
is eatablished that the equi11brium constanta are not equal. 
The evidence presented so tar suggests that the polar 
groups l1berated 1n step 1 are involved 1n hydrogen bond formation 
in steps 2 and 3. Since tlbrin clots and lntermediate polymers 
are depolymerlzed by solvents whlch break hydrogen bonds it 1. 
probable that, ln the absenoe of calcium 10ns and 'ibr1n-Stabill-
zlng 'actor (sectlon VII), intermolecular hydrogen bonds rather 
than covalent bonds are tormed ln steps 2 and 3. At one time 
electrostatic ettecta were postulated to play a role in polymeri-
zation. In vlew ot the ready oompatibility ot the hydrogen 
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bonding theory with experimental obeervations, electrostatlc ef-
fects are presumed to play only a mlnor role ln thelr effect on 
the pK'a of the dissoclatlng groups. 
The aooeptor croups A are considered to be avallable on 
the orlglnal fibrinogen molecule but the donor groups DH are 
thought to be maaked by the flbrlnopeptldea. Thea. donor groups 
become available tor polymerization when the flbrlnopeptide ls 
11berated ln step 1. Step 2 then involves the formation of lnter-
molecular hydrogen bonda between alde chain groups accordlng to 
the equation (44): 
The non-hydrogen bonded donor and acoeptor groupa are 
themaelves involved in equillbria of the type 
DH 
AB 
-
-
-
-
8. 
It has been suggested that hlstldyl groups (64) and 
amlno and tyroayl groups (27) are lnvolved ln the polymerization 
process. Seta of hlstidyl groups on flbrln monomers oould well 
function as the acoeptor altes tor the tyroayl or lysyl donors an 
thus lead to polymerization. 
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The pH range of polymerization can be accounted tor in 
terms of the above mechaniams. The tyrosyl donors (pK approxi-
mately 9.5) would 108e their protons above pH 10.5 while the hi.-
tidyl acceptors (pK approximately 6) would acquire protons below 
pH 5.5 thus enabling steps 2 and 3 to occur only in the pH 5.5 to 
10.5 region. 
The etfect of pH on polymerization and conversely the 
eftect of polymerizat10n on pH can be treated quant1tatively by 
taking into acoount the degree of dissociat1on of both DR and AH 
and the etfecta hydrogen bonding has on these d1saociationa (27, 
62). This thermodynam1c theor,y provides strong evidenoe that the 
polymerizat10n of fibr1n monomer takes place through a hydrogen 
bonding mechanism involving about 19 tyroayl donora and about 19 
histidyl acceptors. Although presumably 19 such donors or accep-
tors are unmasked by the release of tibrinopeptide, the actual 
number of hydrogen bonds formed per link depends on the pH, the 
average maximum being about 9 bonds, near pH 8. 
An idealized schematic representation of F and f to show 
the functionality with respect to polymerization is shown in Pig. 
VI (10). These representations are schematic and do not 1mply 
that the molecules of F and f are h1ghly asymmetrical. It 1s pre-
sumed that the acceptor site Al cons1sts ot 19 h1st1dyl groups and 
the donor s1te DlH of 19 tyrosyl groups and that the aUX1ll1ary 
acceptor and donor s1tes A2 and D2H conta1n fewer hydrogen bonding 
Fig. VI. 
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F f 
Copolymer ~ A2 AI mlJT1 Lf.J 
we,,! 
PI 
r+, 
D2H A2 
Idealized sohematio representation of fibrinogen 
(F) and fibrin monomer (f) to show the function-
ality with respeot to polymerization. The hydro-
gen bond donor and acceptor ,roups are represented 
by DR and A respeotively (10). 
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groups. When peptides A and B are liberated in step 1, the donor 
(or acceptor) groups are unmasked. If this representation is true 
then not only can f polymerize to form fibrin but there is the 
possibility that a copolymer can be formed (between f and F). P 
molecules would in this case serve as chain terminators. In the 
presence of thrombin these "dead ends" could be reactivated by 
step 1. However, Sherr.J, et al, (32) have thrown considerable 
doubt on copolymer formation. Fibrin monomer (0.18 me/ml) pre-
pared in 1 ! XaDr, as described previously, was allowed to repoly-
merize in the pre.ence of added fibr1nogen (0.18 m&lml) and the 
rate of clot formation followed by OD measurements. ~here was no 
increase in either rate or amount of polymerizat10n (clot forma-
tion) over that occuring without added fibrinogen thus showing 
that copolymerization plays no signif1cant role in the process 
when tibrin monomer and fibrinogen are present in equal amounts. 
The S8me workers also polymerized fibrin monomer in the presence 
of added thrombin and aga1n no increased polymerization took place 
showing that thrombin plays no detectable role 1n the polymeriza-
tion process. 
VII. STEP ~ 
The tinal step in the fibrinogen-fibrin convers1on 1n-
volves the aggregation ot the intermediate polymers to form a gel. 
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In the absence of calcium ions and fibrin stabilizing factor (FSr) 
this gel can be reversibly dispersed in a number of solvents such 
as urea or NaBr (10). 
In the course of normal blood coagulation or in the 
presence of calcium ions and FSr, the gel produced is insoluble in 
urea and NaBr. This has led Lorand (36) to suggest that in this 
case the gel should be regarded as a true polymeric network in 
which the polymers are linked by covalent bonds. In this reactio~ 
'SF i8 only the precursor of the active polymeriZing principle 
(rsr*) which arises from the action of thrombin on rsr. The re-
action a180 requires calcium ions. 
psr 
fibrin aggregates 
Thrombin 
• rsr 
• rsr 
fibrin polymer 
10 • 
11. 
Lorand proposed that the crucial feature of the reaction is a 
transamidating mechanism in which some of the X-terminal glycine 
residues of one fibrin molecule react with possibly an activated 
carbonyl of a neighbouring flbl'ln molecule to form a peptide bond. 
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The properties of fibrin clots vary considerably between 
those of two extreme types referred to as fine and coarse clots by 
Ferry and Morrisson (16). Both types of clot are envisaged as 
cross linked gel structures with large amounts of liquid held in 
the interstices between the fibrin strands, the coarse clot being 
aggregated laterally to a greater extent than the fine clot. 
Electron micrographs ot stained specimens show alter-
nating light and dark bands indicating a periodic1ty in the fi-
brillar structure. Prom measurementa of the distances between 
dark banda, it has been suggested (20) that in polymer1zation, the 
fibrin monomera shrink to one halt their length and aggregate lat-
erally. In view of the fact that step 3 is reversible and that 
this reversib11ity can be brought about in hydrogen-bond break1ng 
solvents, the 1ndication 11 that hydrogen bonding i8 involved in 
step 3 aa well as step 2. 
CHAPTER II 
KINETICS AND THIRMODYlfAMICS OF THI J'IBRIHOOD 
FIBRIN CONVIRSION 
1. Kinetics 
The fibrinogen - fibrin conversion i8 conven1ently rep-
resented by the fo1lowins scheme. 
Step 1. 
Step 2. 
Step 3. 
Proteolysis 
Po111lerization 
Clotting 
'1' 
F ---' .... f + Peptides 
nf • fn 12. 
m(fn ) .. fibrin 
The fact that tour pep tides can be liberated in the pro-
teolysis step (7) and that these tour peptide a (2 ot A and 2 of B) 
are liberated at ditferent rates (4) makes a complete discuasion 
of the kinetics of even step 1 difficult. The situation is fur-
ther complicated since polymer1zation of fibrin monomer (f) pre-
sumably starts aa soon as f is produoed. 
Although the overall process in the olotting of even 
highly purified fibrinogen by highly purified thrombin i8 quite 
complex, significant progress in the unaeratanains of some aspect 
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of the fibrinogen - fibrin conversion has been made in the past 
few years. 
Waugh and Livingstone (6{) investigated the kinetics of 
the overall reaction using bovine fraction 1. The thrombin - fi-
brinogen reaction was allowed to proceed to a clot, the reaction 
being stopped at various stages by the addition of formaldehyde 
(final conoentration 1.8~). The supernatant from the clot was 
analysed for unreacted fibrinogen by U.V. absorption. From the 
results so obtained, In Fo/F was plotted against time. These 
curves exhibit an initial curvature and then a linear (first or-
der) protion similar to the opacity ourve shown 1n Fig. X. The 
authors assume that in the linear portion, which in their experi-
ments extrapolates through the origin, the fibrin clot keeps the 
concentration of intermediate polymers low so that the kinetic 
data pertain to step 1. The linear portions of all reactions 
studied ('0 = 0.036 to 0.36 mg/ml at pH 6.85 and ionic strength 
0.15) conform to the equation 
0.483 To 
In FoI' 
-
-
t 13. 
where To and '0 are the initial thrombin and fibrinogen concentra-
tions. This equat10n shows that the reaction is f1rst order in 
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thrombin but departs from first order behaviour in fibrinogen. 
The validity of the above results has been questioned by 
Ehrenpreis and Scheraga (14). Thea. workers were able to show 
that formaldehyde, in the concentrations used by Waugh and 
Livingstone does not completely inhibit thrombin but does inh1b1t 
the polymerization steps. Theae authors ma1ntain that because the 
polymerizat1on steps are not instantaneous and because formalde-
hyde does not completely 1nh1bit thrombin activity, the use of 
formaldehyde as a stopp1ng agent is not valid. 
Bhrenpreis and Scheraga (14) studied the kinetics of 
step 1 using a h1gh concentrat10n of TAMe (p-toluene sulfonyl L-
argin1ne methyl ester) as a thromb1n 1nhibitor. In these experi-
ments, f1brinogen concentrat10ns of 0.2 and 2.0 m&/ml, and a 
thrombin concentration of 0.05 u/ml were used at 25°, pH 6.8, 
ionic strength 0.15. The react10n was allowed to proceed and was 
stopped at var10us stages by add1ng TAMe. After TAMe add1t1on the 
solutions were kept at room temperature for about 16 hours to 
allow step. 2 and 3 to go to complet1on. The supernatants from 
the clot were analysed for unreacted fibr1nogen by V.V. abSOrp-
tion. The re8ults of these exper1ment8 1ndicate that 8tep 1 1s 
first order in Fibrinogen with essentially no dependence of the 
first order rate constant on the initial fibrinogen concentrat1on. 
Using the same method and under the same condit1ons as 
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above, Soheraga and Ehrenpreis (46) obtained values of the tirst 
order rate constant (kl) tor step 1 at pHis ranging trom 6 to 9. 
These results show that the maximum value of kl (a.5/minjTAMe unit 
of thrombin) occurs at about pH 8. 
Kinetic data on step one ln 1 ! NaBr at pH 5.3 (where no 
polymerization occurs) were obtained by following the rate ot pro-
duction of fibrin monomer, again using TAMe as a thrombin inhibi-
tor, by Ehrenpreis, et al (15). Under these conditions it was 
necessary to work at low temperatures (0°0), with high thrombin 
(100 u/ml) and fibrinogen (30 mslml) concentrations and with long 
reaction times (up to 6 days). Analysis ot the data indicated 
that the reaction i8 first order with respect to both thrombin and 
fibrinogen. The authors concluded that step 1 appeared to be a 
simple bimolecular reaction to torm the enzyme-substrate complex 
under conditions where the enzyme is not saturated. 
Mihalyi and B111ick have presented a kinetic analysis 
of the pH changes associated with the conversion ot f1brinogen 
into tibrin (39). The method used gives a direct .stimate of the 
hydrogen ions liberated, or taken up, during the overall reaction. 
This method ls unable to distinguish the two polymerization steps 
(It indeed there is a dlfterence) and the entire polymerization 
process is treated as a slngle step. 
Using an initial fibrinogen concentration ot l.37~, 
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ionic strength 0.3, thrombin 1 TAMe u/ml at 250 , continuous re-
cords ot pH changes with time were obtained. The recordings ob-
tained below pH 8 indicated that hydrogen ions are released ac-
cording to a tirst order reaction law over more than 90~ ot the 
reaction. The rate constant calculated trom these results ahows 
a steady increase trom pH 5.7 to pH 8.0. Above pH 8 the pH re-
cordings have a biphasic character. First the pH decreasea, 
reaches a minimum and then increaaes and levels ott betore attain-
ing the initial value, indicating the presence ot two reactions, 
one producing the other absorbing hydrogen ions. The biphasic 
curves were analysed in terms ot two opposing simultaneous tirst 
order reactions and the authors concluded that one reaction corre-
sponded to the proteolysis step and the other corresponded to the 
polymerization step. The rate constants calculated tor the two 
reactions are plotted alalnat pH in Pig. VII. The rates ot the 
proteolysis step calculated trom the biphasic curves (i.e. above 
pH 8) tit smoothly with the pOints ot the single reaction on the 
acidlc side. Thi. data al.o shows that the polymerization step 
(k2) i. slower_than the proteolysis step (kl); with a kl 2.5 time. 
greater than k2 at pH 8 and assuming that the curve can be extrap-
olated, kl 1.5 times greater than k2 at pH 7.5. 
The authors propose that hydrogen ions are involved in 
both the proteolysis reaction and the polymerization reactions 
with the net production or absorbtion of hydrogen ions depending 
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rig. VII. Rate constants ot the tirst • and of the secondo 
reactions plotted against pH. fibrinogen concen-
tration in the tour experiment. collected in this 
figure varied Qetween 1.02 and 1.44~, Ionic 
strength 0.30, temperature 25°. (39) 
on the init1al pH. The reaction at the two extreme pHiS of the 
clotting reaction can be written as follows: 
ElL§. ~H 10 
1 nF ... nf nP • nf ..- nH+ 
2 nf ... f'n + nH+ nf + nH+ ~ fn 
Overall nF .. f'n -t- nH+ n' • fn 
F • fibrinogen, t • fibrin monomer, fn • fibrin polymer, 
n • a variable number. 
14. 
Because the titration ranges of the groups concerned 
overlap to a considerable degree, hydrogen ions are liberated by 
both the first and the second step when the reaction is carried 
out at an intermediate pH. 
The first order dependence on fibrin monomer concentra-
tion of the polymerization step can be implied from the results of 
Sherry et. ale (32). Fibrin monomer was prepared in 1 ! NaBr, as 
described previously. This was then allowed to polymerize at room 
temperature in 0.1 ! phosphate buffer at pH 6 and the course of 
the polymerization followed by absorbance measurements at 350 mu. 
Initial fibrin monomer concentrations of 0.15 to 0.6 m&lml were 
used and the curves shown follow a first order reaction course. 
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From these experimental curves; the rate constant for polymeriza-
tion was calculated to be about O.2/min at pH 6, ionic strength 
0.1) room temperature (20-25°). 
A summary of the kinetic oonstants pertaining to the 
proteolysis step 1s given in Table III. 
2. Reveraibilit, and ThermodlPamica. 
Laskowski, et. ale (30) have investigated the equilibri-
um ot step 1 in 1 ! HaBr, pH 5.3 at 0°, 150 and 25° under condi-
tions similar to those used by the same group to study the kinet-
ics of step 1. This equilibrium was investigated over a range of 
concentrations and temperatures by determining the concentration 
of t (monomer) in the reaction mixture at equilibrium, the equi-
librium being approached trom both sides (i.e. using both forward 
and reverse reactions). 
By analysing for r, the degree ot reaction 0( J can be 
computed at any time during the course of the reaction, 
(r) 
01.. = 
(1') + (t) 
where the parentheses denote molar concentrations. 
15. 
Flbrinogen 
!llml 
30 
30 
2.0 
0.2 
0.2 
0.2 
0.2 
13.7 
13.7 
l3.'r 
13.7 
TABLE III 
St1MMARY 01' KID'l'IC COHSTAWl'S FOR S'l'BP 1 
Temp. 
00 
Solvent 
or Butfer 
Ionlc 
Strength 
pH • Thrombln 
TAMe u/ml 
0 lfaBr 1.0 5.3 100 1. '7%10-6 
25 lfaBr 1.0 5.3 100 5.0%10-5 
25 Phosphate 0.15 6.8 0.045 1.55 
25 Phosphate 0.15 6.0 0.045 0.183 
25 Phosphate 0.15 7.0 0.045 1.49 
25 Phosphate 0.15 8.0 0.045 2.50 
25 Phosphate 0.15 9.0 0.045 0.93 
25 Phosphate 0.30 6.0 10 0.06 
25 Phosphate 0.30 7.0 10 0.19 
25 Phosphate 0.30 8.0 10 0.46 
25 Phosphate 0.30 9.0 10 0.34 
• 1 TAMe unlt Is the amount of thrombln whlch hydro-lyzes 0.1 umole ot TAMe in one minute at pH 8.0 
and 250 trom 0.01 M TAMe solution in 0.15 M KOI. 
- -
Ref. 
(15) 
(15) 
(14) 
(46) 
(46) 
(46) 
(46) 
(32) 
C~) 
(32) 
(32) 
w Q) 
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Pig. VIII shows a plot of « va time at 00 for an initial 
fibrinogen concentration of 30 mg/ml and in which equilibrium waa 
approached from both sides. Two important observations are imme-
diately apparent; first, the values of ~ in the forward runs do 
not reach unity and secondly the values of ~ decrease in the re-
verse experiments, approaching the equilibrium values of the for-
ward runs. These results provide strong evidence that step 1 is 
reverSible since essentially the same equilibrium position is 
reached trom both directions. 
If step 1 ia represented as 
F __ >f+ P 
then the equilibrium constant will be given by 
K • 
1 - 0( eq 
16. 
1'7. 
If this is the case then the values of ~eq at a given 
temperature should be dependent on Po. However, when the initial 
fibrlnogen concentration (Fo) was varied from 10 to 30 mg/ml it 
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6 
0.8 
0.6 
0.4 
2 4 
TI ME (days) 
Pig. VIII. Variation of 0( with time tor forward 0 and 
reverse • runs at 00 in NaBr. "0 • 30 mg/ml, 
thrombin • 100 TANS u/ml. (30) 
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was found that the equilibrium values of 01.. (deq ) were essentially 
independent of Fo. Step 1 must therefore De modified 80 that an 
equation ot the form 
CXeq 
K • 18. 
111 hold. That ia~ atep 1 should be formulated in a manner such 
that the total number of molecules does not change. II' it 1s 
s8umed that P and f are associated even after hydrolysis (e.g. by 
side chain hydrogen bonds) then step 1 can be written as 
f···P 19. 
ith an additional eqUilibrium for the dissociation of the f ••• P 
complex 
f •• ·P < >- f + P 20. 
It nas been shown ~rev1ously (Chapter I) that at least 
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two types ot peptide, PA and Pa are involved in step 1 and that 
there are two molecules ot each peptide per molecule ot tibr1nogen 
ot 340,000 molecular we1ght. Taking account ot only the type and 
not the number ot peptides these equi11bria can then be written as 
in 'ig. IX. 'orm I 1s tibr1nogen; torms II and III represent mol-
ecules in which a peptide bond has been hydrolysed, but the re-
sulting peptide. PA and Pa are still associated with the remainder 
ot the molecule. 'orm IV i. a species in which two peptide bonds 
have been hydrolysed but both peptides are associated with t. 
Equations a, band c ot 'ig. IX represent dissociation reactions. 
Laskowski et. ale (30) also carried out Similar experi-
ments at 150 and 250 and by plotting log K vs lIT, a value ot 
ABO • 8 Kcal/mole was obtained. Prom this and the values ot 
~,o obtained from the K values at the three temperatures a value 
ot A SO • 32 cal/mole/deg. was obtained. 
It it is assumed that the hydrolys1s ot the pept1de bond 
is accompanied by the rupture ot some but not allot the s1de 
cha1n hydrogen bonds in the formation ot the t ••• p complex and 1t 
all hydrogen bonds are equivalent and ot the heterologous s1ngle 
bond type then it can be shown (28) that 
• A~ + 21. 
II .... p 
.... a 
t" 
~ '" P'b ~ /a /"P a r/ 
r"" , IV I P , 'p Pb ~ b /Pa 
f, 
, 
III 
'p 
b 
" 
.... Pa 
<a) r" ::.. Pa f r--Pb V 
'""P 
'< 
b 
(b) 
/fa 
=-- Pb f.-p VI f, + .... a , 
'P b 
" 
"fa 
(0) r" :00. p + Pb + f VII , .... a , 
'P b (in two steps) 
riC. IX. Sohemat1c representation of step 1. (30) 
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Where ~ HO 18 the experlmentally determined enthalpy.'J .t::,. HO ls the 
ob P 
value to be expeoted tor a slmple peptlde, 6H~J is the enthalpy 
of format1on of an lnternal hydrogen bond and p is the number at 
bonds involved. Us1ng values of -1.55 and -6.0 Keal/mole tor ~UO p 
and c1 H~J and the exper1mental value at 8 Kcal/mole tor .d H~b" a 
value at p • 3 ia obtained trom equation (21) indicating that 3 
hydrogen bonds are broken ln the prooes8. The neceaalty to rup-
ture these hydrogen bonds thus provides some stabil1ty to the pep-
tide bond to prevent the hydrolysis from going to completion. 
Attempts at detemining A H calorimetrically proved un-
successtul because ot the very slow rate of the reaction at pH 5.3 
and when it was determined at pH 6.1 where the reaction is faater .. 
a value ot zero was obtained. A similar result can be interred 
from the data of Lakl (26). A pH dependence ls therefore postu-
lated for thls parameter and auch a dependence would aria. If the 
p hydrogen bonds are oarboxyl-carboxyl dlmer type bonda rather 
than heterologous slngle bonda. 
Step 1 can therefore be regarded aa lnvolvlng proteoly-
sls .. wlth the formatlon at an f·.·P complex accompanled by the 
rupture of one carboxyl-carboxyl double hydrogen bond. The pep-
tide remains assoclated to the fibrin monomer core even after pro-
teolysls. Kay and Marsh (24) have shown that no optlcal rotatlon 
change accompanles step 1 and conclude that the groups necessary 
for polymerization (step 2) appear in an unmasking or uncovering 
of groups rather than in a rupture of side chain hydrogen bonds 
when P is dissociated from the f ••• ' complex. The tact that this 
dissociation i8 highly pH dependent thus accounts for the lack of 
polymerization at low pH's. The sole necessity tor a thrombin in-
duced proteolySiS tollowed by dissociation ot the peptide appears 
to be to liberate the donora (or acceptors) thus making them 
available tor the polymerization reactions (step 2). 
CHAPTER III 
MATERIALS, METHODS A)I1> PRELIMINARY STUDIES 
A. FIBRINOGEN 
1. Purification 
Fibrinogen waa puritied by auccesaive ammonium sulfate 
precipitation ot commercially obtalned bovine fibrinogen (Cohn 
Fraction 1) (25). Six grams ot fibrinogen (Slgma F-92-B93) was 
dlasolved in 300 ml. of 0.15 M KCl (pH 6.3), allowed to stand 
overnight in the refrigerator and the small amount of precipltate 
which formed, fl1tered. The solution was warmed to room tempera-
ture and then saturated ammonlum sulfate solution added dropwise 
with stlrrlng to bring the solution to 18,22,25,30 and 35~ satura-
tion. At each level of saturatlon the preCipitate formed was cen-
trifuged, (10 mins., 10,000 rpm, 250 C), drained of excess superna-
tant and then dissolved in the minlmum amount of 0.15 M KC1. At 
no tlme dld the temperature exceed 270 • '1'0 remove excess ammonium 
Bulfate the solutlons were fl1tered and dlalysed against 5 liters 
0.15 M KCl overnight in the refrigerator (4°). In some cases a 
gel formed ln the dialY81s bag which redissolved on warming to 
room temperature. In one case this gel was removed, dissolved and 
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treated as a separate fraction (P2 gel, Table IV). 
During the precipitatlon the protein precipitated as a 
gel up to about 20~ ammonium sulfate saturation and then precipi-
tated as discrete partlcles. When the above procedure was re-
peated the 18-22% fraction was divided into gel and discrete par-
ticles (OP2 and P2) and treated as separate fractions. A further 
fraction was obtained during dialysis, as above. 
These fraotions were then clotted with thrombin and the 
% non-clottabillty (~C) determined at 0.5 ms/ml fibrinogen. The 
%.Ne was also determined by the Laki method (see below) for compar-
lson. The results obtained are shown in Table IV. 
From the data of Table IV 1t can be seen that the start-
lng material (Sigma P-92-B93) contained 50% protein of which 69% 
was clottable. Pibrinogen fraotionated below 22~ ammonium sulfate 
saturation was fairly consistent with reapect to ~C and waa 89-
94~ olottable, but that fractionated above 22~ saturation was vir-
tually non-clottable. It ia also apparent that material precipi-
tating as gel is conSistently purer than material precipitating as 
discrete particles, 
The preparationa were stored either as the frozen solu-
tion or were lyophilized and stored at _20°, 
2. Clottability of Pibrinogen 
The purity of fibrlnogen preparatlons is normally 
Fraction 
Exp.1. 
Original 
P1 
P2 
P2ge1 
P3 
p4 
P5 
Supernatant 
Exp.2. 
Orig1nal 
Pl 
P1gel 
P2 
GP2 
P3 
TA:a.LE IV 
PURIFICATION OF FIBRINOGEN 
** %AmS04 Vol WIle Fibrinogen 
Saturation m1. mg./m1. Total mg. 
0 300 10.25 3075 
0-18 41 4.3 176 
18-22 70 5.3 371 
18-22 62 5.6 348 
22-25 25 3.4 85 
25-30 27 3.3 89 
30-35 29 3.1 89 
462 0.2 92 
0 300 10.9 32'70 
0-18 65 6.0 390 
0-18 40 5.8 232 
18-22 63 10.3 650 
18-22 93 9.8 910 
22-25 48 2.2 106 
48 
~C* 
-
31.0 
9.9 
11.0 
6.7 
65.0 
101 
99 
99 
7.1 
6.6 
8.2 
5.9 
53.5 
.By the Lakl method the Pl" P2 tract10ns were 4.8-3.7 ~C • 
* Average of two determinations. 
** Calculated on the bas1. ot 1.60 OD-280/mg./ml. (13) 
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estimated by measuring the amount of a preparation that can be 
converted into an insoluble fibrin clot. The method most widely 
used and the one usually quoted 1n the literature when descr1bing 
fibrinogen preparations 1s that of Lak1 (25). 
In th1s method~ the following m1xture i8 prepared. 1 
ml. f1br1nogen solut1on (about '7-8 m&/ml.), 0.1 ml. buffer pH 6.1 
(3 parts 0.5 M KHaP04, 1 part 0.5 M Na2HP04), 2.5 ml. water. To 
this 18 added 0.1 ml. thrombin solution, (Parke-Dav1s dissolved 
1n water and diluted to 250 u/ml.) and the solution mixed. The 
clot which forms is removed after 1 hour and the oD-aBo of the 
supernatant is measured. 'rom this and the OD-2Bo of the or1g1nal 
fibrinogen solution (converted to the aame dilution aa in the 
above method), the amount of f1brinogen taken up aa 1nsoluble clot 
can be est1mated. When expressed as ~ thia 1s the ~ clottab111ty. 
Conversely, 100 - ~ clottab11ity gives ~ non-clottability (~C) 
of the preparation. 
Although this is undoubtably a good method for comparing 
difterent fibrinogen preparationa, it does not give the amount of 
non-clottable material found under the experimental conditions 
used in this study viz., pH 7.4 Tris-acetate ~ = 0.15. Conae-
quently, the %Ne reported in thia study, unless otherw1se stated, 
is that determ1ned in pH 1.4 Tris-acetate, and at the f1brinogen 
concentrat10n existing 1n the Tris-acetate aolut1on. This method 
is as follows. 
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Three ml. of TriB-acetate is added to a 1 cm. Beckman 
silica cell and the absorbance at 280 mp. measured. Fibrinogen 
solution is then added and the absorbance meaBured again. One or 
two units of thrombin are then added l the solution mixed by inver-
sion and the OD-310 i8 measured at 30 minute intervals. When the 
OD-3l0 has reached a maximum, (about 90-120 mins) the clot is re-
moved using a tine copper wire loop and the 0D-2Bo of the super-
natant is measured. Necessary corrections are made to allow for 
Tris-acetate dl1ution and thrombin absorbtion. From the original 
and flnal OD-280 meaBurements l the ~C can be estimated. 
3. Rate of Clot 'ormatlon 
The rate at which the flbrin clot is formed can be est1-
mated by measuring the rate of increase In OD-310 of a solution 
contalning fibrinogen and thromb1n. The method also gives a meth-
od of estimatlng the clottlng tlme 1.e. the time taken to the 
first appearance of clotted material. 
A Beckman DU spectrophotometer and a Photovolt model 43 
Llnear-Log recorder was used to measure clot opaCity. The flbrin-
ogen solution is placed in a 1 cm. 8ilica cell and the Beckman and 
recorder adjusted so that wlth the solution in the light path the 
recorder shows an absorbance of 0.02 or 0.03. A measured amount 
of thrombin is then blown into the fibrlnogen solution and at the 
same time the recorder chart i8 started making the time of mix! 
• 
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The solution 1s mixed by inverting the cell three of four timea, 
qu1ckly replaced in the Beckman cell holder and the recorder pen 
switched on (lapsed time about 15 sees.). A record of the rate of 
increase in OD-310 1s thus oota1ned. A typical record obtained in 
this way 1s shown 1n J1g. X. Bw project1ng the in1tial sharp in-
crease in OD-310 back to the base measurement an est1mate of the 
clotting time (tc ) is obtained. Other parameters measured are Vo' 
the init1al sharp increase in OD-3l0 and VI the slope of the tan-
gent to the slower increases in OD-3l0 wh1ch passes through zero 
time. 
4. Calibration of Clot 0Racitl 
To obtain mean1ngful data from the opacity-t1me record-
ings it was neoesaary to oalibrate the opac1ty of the clot at 
OD-3l0 with the amount of fibr1nogen in the olot. It was most 1m-
portant to ca11brate these two quantit1es when the opac1ty of par-
t1ally formed and completely formed clots were being measured in 
order to establish the proport10nality ot clot opacity during the 
process of clot format10n w1th protein concentrat1on. 
Th1s calibration waa carr1ed out aa tollowa. F1brinogen 
at vary1ng concentrat10ns 1n pH 7.4 Tria-acetate waa clotted with 
Parke-Davia thromb1n (0.065 u/ml). The OD-3l0 was measured after 
reach1ng a maximum, the clot was removed with a tine copper wire 
o 
, 
, 
-11 1M 
tHOTOVOlTfORPORATION. NEW YORK CITY 2 
T. 
MINUTES 
Pig. X. An actual record of the increase in opac1ty 
at 310 ~. due to clot formation. 
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and the ribrinogen remaining in solution determined by measuring 
the OD-280. From a knowledge or the OD-280 barore and after clot 
formation and the OD-3l0 or the clot, it was possible to calibrate 
OD-3l0 or the clot with the amount of ribrinogen incorporated 
( A OD-280) in the clot. 
The calibration was carried out on partially formed 
clots by making use of the fact that at low thrombin concentra-
tions, ir a clot is removed berore the reaction is complete suffi-
cient time elapses to make an 0D-280 measurement before clot can 
again torm. Records were made ot the rate of increase of OD-3l0, 
then using identical fibrinogen and thrombin solutions, the clot 
was removed after various lengths of time and the OD-280 quickly 
measured. From a knowledge ot the original OD-280, the OD-280 
immediately after clot removal and the 0D-310 at the corresponding 
time from the record, calibration was possible during clot forma-
tion. Pig. XI shows the result. obtained w1th pur1fied fibr1no-
gen (Pl), uaing both the above methods, demonstrating that the 
clot OD-3l0 1s directly proportional to the amount of ribrinogen 
in the clot and that the same calibration holds tor partially 
formed clots. Theretore opac1ty meaaurements ot the rate or clot 
formation can be expressed in terms or mg. flbrlnogen/ml./mln. 
5. Extinctlon Coefficlent of 'lbrlnogen 
The extlnction coefficient for fibr1nogen has been 
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'is. XI. calibration of clot opacity at 310 mu. with the 
amount of fibrinogen in the clot. • data troll 
fully formed clots, 0 data from partially 
tormed clots. 
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reported as 16.0 for 1 g./IOO mI., 1 cm. cell, 280 mp. by 
Ehrenpreis and Soheraga (13) 1.64 OD-280/mg./ml. by Hartley and 
Waugh (21) and 16.51, 1%, 1 cm, 282 ~. by Blombaok (7). 
In this study a value of 1.6 OD-280/mg./ml. for fibrin-
ogen will be assumed. Calibration of absorbance at 280 mp. and 
290 mp. has been carried out, 1t being found that 1.0 OD-290 1s 
equivalent to 1.4 OD-280. 
Therefore the opt1cal dens1ty of a solution of 1 mg. 
fibr1nogen/ml. is equ1valent to 1.6 at 280 mu. and 1.15 at 290 ~. 
B. THROMBI.N 
Thrombin was purified by ohromatography ot Topical Park 
Davis Thrombin, (Bovine Origin). Two methods were used, one using 
phosphate oellulose and the other using Amber11te IRC-50 (XI-64). 
The thromb1n obtained from the IRC-50 puritioation was prooessed 
through a Sephadex oolumn in order to transter the thrombin from 
the phosphate butter to Tris-acetate bufter. 
1. Purification 
a) Chromatograph, on Phosphate Cellulose 
A moditioation to the method of Seegers (52) was used in 
whioh the thrombin is absorbed at low ionic strength and eluted 
With buffers of inoreasing ionic strength. 
The following 9hosphate buffers were used:-
Stock Buffer, pH 7.0, 0.10 ! 
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5.382 g. NaH2P04.H20, 21.9 g. Na2HP04.12H20 dissolved 
and diluted to one liter with distilled water. 
Buffer A: pH 7.0, 0.01 ! 
100 ml. Stock buffer diluted to one liter with distilled 
water. 
Buffer Bs pH "1.0, 0.05 J( 
-
500 ml. stock buffer diluted to one liter with distilled 
water. 
Buffer D: pH 8.0, 0.30 J( 
-
diluted to one liter with distilled water. 
Buffer C: pH 8.0, 0.15 M 
-
500 ml. Buffer D diluted to one liter with distilled 
water. 
~he cellulose phosphate used was Celu Ion P (phosphoryl-
ated Whatman cellulose), Nutritional Biochemicals Corp. Control 
No. 9732. Celu Ion P was stirred with bufter A using a masnetic 
stirrer for 10 mins. and the supernatant decanted. The process 
was then repeated. A 21 X 0.9 cm. column was then poured under 
gravity and buffer A passed at maXimum rate (3.5 ml./min.) for one 
hour, after which time the pH of the eluent was 7.1. 
The thrombin used was Topical Parke-Davis Thrombin, 
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(Bovine) Bio 2077, stated as being 1000 NIH units per vial, Lot 
090345 A. One vial was dissolved in 2.0 ml. distilled water and a 
0.1 ml. sample removed and added to 5 ml. pH 1.4 Tris-aoetate 
bufter and assayed for thrombin aotivity and protein. The oolumn 
was drained to bed level and the thrombin solution applied to the 
oolumn. This was allowed to drain in and followed by 3 x 2 ml. 
washings of buffer A. The oolumn was then oonneoted to a reser-
voir and the buffer solutions passed at a rate of 15 ~ 1 ml./ 
hour. Each fraction was assayed for protein by measuring the ab-
sorbance of the ettluent at 280 mp. and for thrombin activity 
using clotting Method A. The butfer was changed after the elution 
ot a peak as Judged by the absorbance at 280 m~. The column was 
always drained to bed level when the bufter was changed. The col-
umn was jacketed and the temperature was controlled at 25°C 
throughout the run. The eluate was collected in 5 ml. fractions 
using a Vanguard model 1000 volumatic traction collector. About 
'70% of the protein was eluted atter 20 ml. ot butfer A, but very 
little (2.5~) thrombin act1vity appeared in this peak. Only 
traces of protein and thrombin were eluted with butters B or C and 
only after eluting with the higher ionic strength butfer D did any 
activity appear. 
The fractions which appeared to contain appreciable 
amounts of thrombin by olotting method A were assayed for esterase 
aotivity using TAMe. The purification results are shown 1n Table 
:Fraction 
Original 
3 
4 
21 
38** 
39 
40 
TABLE V 
PURIJ'ICATIOJf O:F THROMBIlf Oli PHOSPHATB-CBLLOLOSK 
ujml. 
1100 
5.0 
6.25 
0.9 
18.9 
11.0 
2.9 
Volume mI. Total u. 
2.0 2200 
5.0 25.0 
5.0 31.3 
5.0 4.5 
10.0 189.0 
5.0 55.0 
5.0 14.5 
0D-28O 
0.284 
2.0 
2.0 
0.170 
0.052 
0.023 
0.003 
* ujOD-28O 
75.7 
2.5 
3.1 
5.3 
364 
480 
970 
* TAMe unit. per unit a baorbance at 280 mu. 
** Two fractions combined. 
Purification 
1 
0.03 
0.04 
0.07 
4.8 
6.2 
12.9 
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v. The data indicatea that Parke-Davia Thromb1n haa about twice 
the atated (1000 NIH unita) activ1ty per v1al and that the best 
purlflcat10n was obtalned by elutlon with the highest lonic 
strength buffer. Tubes 3, 4, 38, 39 and 40 were frozen and store 
at _18°. 
b) Chromatographl on Amberlite IRC-20 (XB-64) 
The method used was that of Rasmussen (43) in which the 
thrombin is absorbed at low ionic strength and eluted at high 
ionic strength. 
The following bufters were used:-
Butter AI 0.05! Phosphate, pH 7.0 
2.691 g. NaH2P04' 4.331 g. Na2HP04, dlss01ved in 
distilled water and made up to 1 11ter. 
Bufter B: 0.30 M Phosphate, pH 8.0 
.... 
water and made up to 1 11ter. 
The resin used waa Bio-Rex '{O, 200-325 .esh, sodium 
form, Control No. 2500, Blo-Rad Laboratoriea. Bio-Rex 70 was 
stirred with 0.3 ! bufter using a magnetic stirrer tor 10 mins. 
and the aupernatant decanted. A 0.9 x 15 em. column was then 
poured under gravity and washed with 100 ml. bufter B. At thia 
point the eluate was pH 8.0. Butter A was then passed (430 ml.), 
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after which the pH waa 7.1. The eluate from the column waa passed 
through a Beckman 10 mm. silica flow cell and the Beckman DU con-
nected to a Photovolt model 43 Linear-Log recorder ao that a con-
tinuoua record of the eluate absorbance at 280 mp. could be made. 
The thrombin used waa Topical Parke-Davia Thrombin l 
(Bovine) Bio 20761 Lot. 030782 A. Sixty five mg. of thia material 
was disaolved in 2 mI. of buffer A and a 0.1 mI. sample removed 
and added to 1 ml. of pH 7.4 Tria-acetate and assayed for thrombin 
activity and protein. The column waa drained to bed level l the 
thrombin solution applied to the column and followed by 2 x 0.5 
ml. of buffer A. The column was then connected to a reaervoir and 
buffer B pasaed at '7 ± 1 ml.jhour. Chromatography waa carried out 
at room temperature (27°). Fractiona were collected manually on 
the basis of the recorded OD-280 and these fractions teated for 
clotting time by method A. The chromatogram is shown in Pig. XII. 
It can be aeen from thia figure that the greater part of the pro-
tein (70~) was eluted after 20 mI. and that very little thrombin 
activity appeared in this peak. The fourth large peak contained 
37~ of the thrombin activity and waa collected as a single frac-
tion (6.6 ml.). Atter removal of a 0.1 mI. aliquot for aaaaYI the 
remainder waa applied to a Sephadex gel column for buffer exchange 
Chromatography on Bio-Rex 70 gave a five-fold increase in apecific 
act1vity with 37~ recovery of total activity. 
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c) Sephadex Gel Filtration 
Sephadex 0-50 (Fine 200/400 mesh) was used and the meth-
od was that suggested by Pharmacia Fine Chemicals (55). 
Sephadex a-50 was slurried with pH 7.4 Tris-acetate 
()J • 0.15). A 7.5 x 1. 'I em. (17 ml.) column was poured and 
Tris-acetate was passed through the column overnight. The eluate 
from the column was passed through a Beckman 10 mm. silica flow 
cell and the Beckman DU connected to a Photovolt model 43 Linear-
Log recorder so that a continuous record of the absorbance at 280 
mp. of the eluate could be made. 
The column was drained to bed level, 6.5 ml. of the 
thrombin peak from the Bio-Rex 70 column was applied and followed 
by 2 x 0.5 ml. Tria-acetate buffer. The column waa then connected 
to a reservoir and Tria-acetate buffer passed at a rate of 4 % 1 
ml./hour. Chromatography was carried out at room temperature 
(270 ). Fractions were collected manually on the Dasis of absorb-
ance measurements and the volumes estimated by counting the number 
of drops of eluate per minute. Fractions of 1.3 ml. were collect-
ed and phospnate concentration was estimated by adding 2 drops of 
eluate to 2 drops of saturated O&C12 and comparing the preCipitate 
formed, if any, with standards prepared from 0.01, 0.02, 0.03, 
0.04, 0.05! pbosphate. The esterase activity of each fraction 
was measured by TAMe hydrolysis. 
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The purification reaults are shown in Table VI. Al-
though mOISt of the purification wa. obtained with chromatography 
on Bio-Rex 70 a further 30~ increase in speciflc activity, with a 
(9~ recovery ot total actlvlt"wa. obtained by gel fl1tratlon on 
Sephadex 0-50. 
The above fractions were frozen and stored at _20°. 
2. Meaaurement of Thrombin ActivltZ 
a) C1ottl91 Activitz 
Method A. An apprOXimate c10ttina time lIethod wae ueed tor the 
rapid eatlmation ot thrombin activity 1n chromatographic eluatea. 
Thrombln concentration waa estimated by lIeaaur1ng the time to the 
first appearance of clotted material when 0.1 Ill. ot thromb1n so-
lution (eluate) Waa added to 0.5 ml. ot flbrinosen aolution (1 S. 
Sigma f91B-213 dlaso1ved in 100 m1. pH 7.4 Trla-aoetate ~ • 0.15. 
Method B. (I.I.H. Clottlng Un1ts) This w.a determlned ualng the 
materlals and methods apeclfied by the Ratlonal Inatltute. of 
Health (40). 
The materlal. were prepared aa follows: 
15~ Gum Acacla. Recrystallized Sum aoac1a, 7.5 s. diasolved in 
and made up to 50 ml. with 0.9~ N.Cl. 
Imldazole Butter: 0.81 g. illldazole disaolved in 45 ml. 0.1 N HCl 
and made up to 50 ml. w1th water. 
TABLE VI 
GEL FILTRATION OF BIO-REX 70 THROMBIN ON SEPHADEX 0-50 
Fraction u/m1. Vo1ulIe Total Phoaphate OD-280 'fAJIIe uLm1 Purification 
Ill. u. M. [0D-280 
Original * 187.5 6.5 1220 0.3 0.319 590 1 
1 0 2.0 0 0 
2 0 2.0 0 0 
3 10 1.2 12 0 0.0'73 '770 1.3 
4 91 1.2 109 0 0.100 910 1.5 
5 142 1.2 170 0 0.187 '760 1.3 
6 262 1.4 366 0.01 0.340 '770 1.3 
7 173 1.5 242 0.02 0.350 495 0.8 
8 43 1.5 65 0.05 0.220 195 0.3 
* Single fraction obtained from Bio-Hex 70 chromatography. 
Standardized Pibrinogen: Sigma P92B-93, (Bovine), Cohn Praction 1. 
1.S g. ot dried powder was dissolved in about SO ml. distilled 
water and the pH adjusted to 7.2 with 0.5 M Na2HP04 (about 2 ml.). 
The solution was then made up to 100 ml. with distilled water and 
filtered. This solutlon was made up tor each experiment. 
Titration Mixture: This was prepared by mixing together the 
tollowing ingredients. 
IS~ Gum acacia 
l~ caC12 in 0.9~ HaCl 
Imidazole butter 
0.9~ HaCl solution 
2 parts. 
1 part. 
1 part. 
5 parts. 
In the method, 0.18 ml. ot the titration mixture is 
placed in a 12 x 75 mm. test tube. Exactly 0.06 ml. ot thrombin 
ia then added (the dilution ot the thrombin will vary and must be 
made 1n 0.9~ HaCl). Standardized fibrinogen, 0.06 ml., ia then 
added with a blow-out pipette and the stop watch Simultaneoualy. 
The first appearance of fibrin i8 the end pOint. When a 15 second 
clotting time ia obtained on repeated teats at 28°c. t 1.00e the 
thrombin concentration in the final clotting mixture is 1 unit per 
ml. The concentration of thrombin in the original aolution is 5 
units per ml., aince it i8 diluted five-fold when added to the 
final clotting mixture. Table Al ot the appendix gives the re-
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suIts obtained using purified thrombin and Fig. XIII shows the 
plot of clotting time against units/mI. thrombin. These results 
were used to calibrate the clotting and esterase activities of 
thrombin. 
b) Esteraae Activ1tl 'TAMe unital 
A modification of the method of Hummel (23) was used, 
Thrombin activity is estimated using p-toluenesulphonyl-L-arginine 
methyl ester (TAMe) as substrate and the oourse ot the hydrolysis 
is tollowed by measuring the rate of increase in absorbance at 
247 mu. using a Beckman DU Speotrophotometer and a Photovolt model 
43 Linear-Log recorder (chart apeed 12 incheS/hour). 
Three mI. of 0.0015 M TAMe 1n pH 7.4 Tria-acetate 
.... 
p • 0.15, was placed in a 1 cm. s111ca cuvette and the Beckman 
and recorder adjusted so that, w1th the solution ln the llght pat 
the recorder lndicated an absorbanoe of about 0.03. A measured 
amount of thrombin was then added to the TAMe solution, the cu-
vette inverted 3 or 4 tlmes, rapldly replaced ln the Beckman cell-
holder and the recorder started. The veloclty of the reactlon was 
calculated from the initial slope of the OD-247, time curves. 
c) Determlnat10n ot K1net1c Constants for TAMe Hydrolls1s 
The Michae11s-Menten equat10n (37) tor an enzyme 
'J 40 Q) 
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Z 
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o 
~ 0 
u 15 ------------------_ I 
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THROMBIN (NIH units/ml.mix) 
Fig. XIII. Clotting time veraua thrombin oonoentrat1on. 
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Temperature 28 ± 10 , pH '1.2. By def1ni tion 
1 u/ml w111 give a clott1ng t1me of 15 aeconda. 
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catalyzed reaction i8, 
22. 
s + ~ 
Where vo = initial velocity, V. = maximum velocity, 
s 
-
-
substrate concentration and 1m = the Michaelis substrate 
constant. 
This equation can also be written in the form 
(Lineweaver-Burke) (33). 
l/v 0 = Km/Vm .l/S + l/Vm 
Using the method described above, values of Vo were 
determined for Parke-Davia thromb1n and for highly purified throm-
bin (fraction '7, Table VI) Table A2 of the appendix ahows the re-
sults obtained and Pig. XIV ahows a plot of l/vo aga1nst l/S. 
Prom Fig. XIV and equation 23, Km was round to be 1. '73 x 10-4 ! 
TAMe. 
d) De tin'! tion 01' TAMe un! t 
In order to calibrate the change 1n optical dens1ty at 
• • , 
50~ 
o 
B 
-4 
I I 
4 8 
TAMe(I03 1/m) 
F1g. XIV. L1veweaver-Burke plot for the thromb1n hydro-
lY81s of TAMe. Curve A 1s pur1f1ed thromb1n, 
2 u/m1., Curve B 18 parke-Dal18 thrombin 
3.5 u/ml. Km = 1.73 x 10- M. 
V. = 0.012 (10D-247/m1n/u/ml. 
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24'7 m)l. during TAMe hydrolysis in terms of ).llI101e/min./ml., two 
0.0015 M TAMe solutions were hydrolyzed with thrombin for several 
days. TheBe solutions were diluted with TriB-aoetate buffer to 
various p-toluenesulfonyl-L-arginine (TA) oonoentrations and the 
OD-24'7 measured and compared to freshly prepared TAMe solutions. 
The extinotion ooeffioient for TAMe is 1260 OD-247/mole/liter and 
for TA is 1830 OD-247/mole/liter. The chaose in OD-247 for the 
hydrolysis of 1 mole of TAMe to 1 mole of TA is therefore 1830-
1260 = 570/liter. Therefore, a ohanae of 1.00 OD-247 is equiv-
alent to 1.75 ~ole TAMe hydrolyzed/ml. Sinoe it is shown in sec-
tion 4 below that INlH unit/ml. of thrombin aotivity is equivalent 
to 0.0120 A OD-247/min., it is also equivalent to 0.021 )lIDole 
TAMe hydrolyzed/min./ml. 
Por the purposes of this study, 1 TAMe unit of thrombin 
will be defined as that amount whioh will give a maximum velooity 
of 0.012 OD-247/min. (0.021 ~mole/min./ml.) when the reaotion is 
oarried out in 0.0015 ! TAMe in pH 7.4 Tris-aoetate ~ • 0.15, 
at 30°. A TAMe unit so defined is then equivalent to a olotting 
unit. 
The initial velooities of the hydrolysis were determined 
using thrombin oonoentrations of' 0.28 to 3.4 u/ml. Pig. XV shows 
-4 maximum velocity, oalculated using 1m • 1.73 x 10 ! TAMe, 
plotted against thrombin oonoentration. This figure demonstrates 
that the reaotion is first order with respect to thrombin 
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concentration. 
3. Calibration of Clotting and Isterase Activity 
This calibration waa carried out by using the aame 
thrombin preparat10n to determine the olotting activ1ty (by method 
B) and the esterase activity (by TAMe hydrolysis). The .steras. 
activity was dete~ined before and after the clotting time deter-
minations and no change was detected. Typical clotting time re-
sults are shown in Table Al and rig_ XIII. The value of the max-
imum velocity of TAMe hydrolysis, V.' correspond1ng to 1 NlH Clot-
ting unit/ml. was determined from the value of the initial veloci-
ty Vo (AOJ)-247/min.) obtained using 1 JUH clotting unit/ml. for 
the hydrolys1s and the Michaelis Menten equation in the form 
Where, in this case Km • 1.73 x 10.4 M TAMe and 
S • 1.5 x 10-3 M TAMe. 
-
24. 
The results obta1ned using various thrombin preparations 
are shown i8 Table VII. 
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TABLE VII 
CALIBRATION or THE CLOTTIMG AND ESTERASE ACTIVITIES OJ' THROMBIN' 
Thrombin 
Parke-Dav'is 
Purified on 
Bio-Rex 70 (Table VI) 
J'raction 3 
Fraction 7 
Fraction a 
Average 
1 NlH Clotting unit/ml 
equivalent to (Vm) 
0.0132 OD-247/min 
0.0115 OD-241/min 
0.0117 OD-247/min 
0.0114 OD-247/min 
0.0120 - 0.0006 OD-247/m1n 
4. TAMe Inhibition of Thrombln Clottin& Actlvltl 
a) Method 
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TAMe can be used to completely lnhlblt the proteolytlc 
react10n (step 1) (14,15). Thrombin 18 added to the flbrlnogen 
solution and reaction allowed to take place. At var10us tlme In-
tervals, a small amount of concentrated TAMe solutlon 1s rapldly 
blown lnto the reactlon m1xture and mixed. The mlxture is allowed 
to stand thus allowlng steps 2 and 3 (polymerlzatlon) to go to 
completlon. The result1ng clot is removed and the remalnlng un-
reacted flbr1nogen estimated from the UV absorption. 
In actual exper1ments the solutlons containing TAMe were 
left about 16 hours to allow steps 2 and 3 to take place and 
blanks were run ln which TAMe was added before the thrombln. It 
was found that only when the orlglnal tlbrlnogen concentratlon was 
higher than 2 m&lml did traces of clot appear 1n the blanks thus 
llmitlng thls method to situations where the orlginal f1brlnogen 
concentrat1on was 2 m&lml. or less. 
The ultravlo1et absorpt1on ot TAMe 1nterferes w1th that 
of f1brinogen at 280 mp. but at 290 mp., where f1br1nogen stl1l 
has cons1derable absorpt10n, th1s 1nterference ls essent1ally neg-
llg1ble (14). Thus the analys1s for unreacted flbr1nogen can be 
carrled out at 290 ~. 1n the presence of TAMe used as the throm-
bln lnhlbltor. 
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The following procedure was used. Four mil1i1itres of 
fibrinogen solution 1n pH 7.4 Tris-acetate buffer were placed in a 
12 x 120 am test tube. Then thrombin ao1ution (usually about 50 
or 100 u1) was blown in and mixed on a Vortex mixer. To atop the 
reaction at any given time~ 0.4 m1. of 0.4 ! TAMe in pH 7.4 Tria-
acetate buffer was blown into the solution and again mixed on a 
Vortex mixer, this serving to break up the clot (if any) and dis-
tribute the TAMe throughout. For blanks, the TAMe waa added firs\ 
followed by the thrombin. The completeness ot thrombin inhibition 
by 'fAMe was shown by the complete absenoe of olott1ns; in the 
blanks. 
0.036 M. 
The oonoentration of TAMe in the "stopped·t solutions waa 
After adding TAMe, the aolutiona were kept at room tem-
perature for a'bout 10 hours to complete the olotting of all of the 
products of step 1, i.e. steps 2 and 3 were allowed to go to oom-
pletion in the atopped solution. After thia time any olot formed 
was removed using a copper wire loop or by filtration, and the 
0D-290 of the supernatant measured. Values of the conoentration 
of unreacted fibrinogen were thus determined as a function of tim_ 
The OD-290 of the fibrinogen remaining in the superna-
tant was calculated aa follows. 
1. Absorption of silica oells and pH l.4 Tria-acetate. 
12 silica cella were used throughout this work and the OD-290 
against air of pH '7.4 Tria-acetate was O.orrS ± 0.003. The re-
sults given in tables are corrected for Tria-acetate absorption. 
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2. Absorption due to TANe. !his was measured by add1n 
0.4 ml. of 0.4 ! TAMe in Tris-aoetate to 4 ml. of Tria-acetate, 
the differenoe in OD-290 between the two giving the OD-2g0 due to 
0.1 ml. 0.4 M TAMe/ml. solution. Thia was done on several oooa-
.... 
sions and was found to be 0.023 ± 0.002. 
3. Prom the measured absorbanoe was deducted 0.023, fo 
absorbance due to TAMe and the result multiplied by 4.4/4 to cor-
rect for the dilution due to the addition of 0.4 ml. of 0.4 ! 
TAMe. This was then taken as being the OD-290 of the unreacted 
fibrinogen. 
b) The Effect of TAMe on the Clottab111ty ot Fibrinogen 
,ibrinogen solutions always contain some material, the 
non-clottables (He) which remains in the supernatant atter remova 
ot the tully formed olot, whether it be non-fibrinogen protein, 
denatured tibrinogen or fibrin monomer and polymers in equilibri 
with the clot. 
The effect of TAMe on clottability was determ1ned by 
clott1ng f1brinogen at various concentrations and then atter abou 
3 hours, when the clot 1s fully tormed, the solut1on was made 
0.036 ! 1n TAMe. This solution was then allowed to stand tor a 
further 3 or 4 hours, the clot removed as before and the OD-290 
ot the supernatant measured. Experiments were also oarried out 
1) without TAMe and 2) add1ng 0.4 ml. 0.4 M KCl instead of TAMe. 
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These results al'e shown in Table A3 and are plotted in Fig. XVI. 
From these r'eaults it can be seen that the highest values for non-
clottables are obtained in the presence of TAMe although there is 
a slight increase due to the presence of KCl (higher ionic 
strength). This would indioate that TAMe has an effect on non-
clottables over and above that due to the increased ionic strength 
it produces. The curves for non-elottables in butfer and for non-
clottables in the presence of added KCl have a common intercept on 
the ordinate which could be interpreted as representing the true 
non-clottable material. The curve for non-clottables in the pres-
ence ot TAMe has an intercept on the abscis8a which again pOints 
to TAMe as having 80me other effect on the non-clottables besides 
the effect due to its ionlc strength. It thus appears 8S though 
some, if not all, of the non-clottable material represents mo-
nomers and polymers in equilibrium with clot rather than denatured 
on non-fibrinogen protein. Beoause of this variation, the non-
clottab18s was determined during any actual experiment so that a 
reliable estimate could be obtained. 
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CHA;PTBR IV 
EXPERIMENTAL RESULTS 
1. Determination of Km and Vm for Step 1. 
The thrombin catalyzed conversion of fibrinosen to fi-
brin monomer is a proteolytic reaction. Since other investisators 
(14,15,32,39,46,67) have shown this enzyme catalyzed reaction to 
be first order with reapect to thrombin and fibrinosen at low fi-
brinogen concentrations, the initial velocities of reaction were 
measured over a wide ranse of fibrinogen concentrations in order 
to determine a Michaelis substrate constant (Km) and a maximum ve-
locity (Vm) for the reaction. These constants can then be com-
pared to the action of thrombin on TAMe and other small substrates 
The initial velocity ot the disappearance of fibrinogen 
from solutions containing varying concentrat1ons of fibrinogen was 
determined by stopping the reaction with TAMe (Chapter III) at 30 
and 60 sec. intervals and comparing the OD-290 of the stopped so-
lution with the original OD-290. The apparent initial velocity is 
given by (Fo-Ft)/t where the subsoripts refer to fibrinogen concen 
trations at zero time and time t. The data from these experiments 
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are shown in Table A4, of the appendix. Determinations were made 
at 30 aeca. and 60 aeca. to verify that initial velocities were 
being measured. Table A4 ahowa that the 30 sec. and 60 sec. velo~ 
ities do not agree very well (i.e. 30 sec x 2 * 60 sec.) and that 
apparently, init1al veloc1t1es were not be1ng measured. Better 
agreement between 30 sec. and 60 sec. veloc1t1es 1s obtained, how-
ever if the value ot the non-clottable protein (Ne), at the fibrin 
ogen concentration concerned, is added to these velocities. This 
implies that the non-clottable protein should be considered as re-
act10n product, that is, that it is fibrin monomer or 1ntermediate 
polymer. The data ot Table A4, corrected tor non-clottable pro-
tein are shown in Table VIII. Table AS of the appendix shows the 
values ot l/vo and 11'0 required tor a Lineweaver-Burke plot. 
A Lineweaver ... Burke "double reci.procal It plot ot the data 
of Table VIII 1s shown in r1g. XVII all velocities being reduced 
to one minute and one un1t ot thrombin. The slope and 1ntercept 
of the straight line were obtained using the method ot least 
squares. An average maximum veloc1ty (Vm> was calculated using 
the value of 1.9 mg./ml. for the Michaelis constant (x.> obtained 
from the plot and the values of each of the initial velocities 
measured. The atandard deviation (a> ot Vm waa calculated from 
the same data. 
TABLE VIII 
INITIAL VELOCITIES OJ' PROTEOLYSIS REACTION 
CORRECTED FOR NON-CLOTTABLBS 
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Corrected for NC 
Reaction Time (Fo-Pt) NC 
J'rom Table A4 
mins. mg/m1 mi/ml 
Thrombin - 0.123 u/m1. 
0.5 0.028 0.021 
1.0 0.084 0.021 
0.5 0.051 0.028 
1.0 0.122 0.028 
0.5 0.072 0.046 
1.0 0.198 0.046 
0.5 0.090 0.086 
1.0 0.298 0.086 
Thrombin - 0.230 u/m1. 
0.5 0.109 0.026 
1.0 0.172 0.026 
0.5 0.161 0.043 
1.0 0.305 0.043 
0.5 0.260 0.082 
1.0 0.517 0.082 
0.5 0.330 0.127 
1.0 0.580 0.12'7 
Thrombin - 0.50 u/ml. 
0.5 0.143 0.022 
0.5 0.273 0.035 
0.049 
0.105 
0.079 
0.150 
0.118 
0.244 
0.176 
0.3'(4 
0.135 
0.lg8 
0.204 
0.348 
0.342 
0.599 
0.45f 
0.707 
0.165 
0.308 
(J'o-'t)/t 
mg/ml/min 
0.098 
0.105 
0.IS8 
0.150 
0.236 
0.244 
0.352 
0.3'74 
0.270 
0.198 
0.408 
0.348 
0.684 
0.599 
0.914 
0.707 
0.330 
0.616 
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Fig. XVII. Lineweaver-Burke plot for the thrombin catalyzed 
conversion of fibrinogen into fibrin monomer. 
Prom these results: 
Km : 1.9 mg. fibrinogen/mI. 
Vm = '7.3 mg./min./unit. (8: 0.6n 
The 95% Confidence Limits for Vm are 6.0 and 8.6 mg./min./unit. 
Assuming a molecular weight of 340,000 for fibrinogen, 
1M • 5.6 ~molesjliter 
V. • 0.021 ~.oles/.in./unit. 
Sinoe Km represents the oonoentration at whioh a reao-
tion is prooeeding at half maximum velooity, the above values in-
dicate that the conversion of fibrinogen to fibrin monomer will 
proceed at the maximum rate of 0.01 ~~min./unit when the concen-
tration of fibrinogen i8 5.6 ~M. 
The values of 1m and Vm for the thromb1n catalyzed hydro 
lys1s of TAMe are Km : 173 ~M. and Vm : 0.021 )1M/min./unit 
(Chapter III). A comparison of 1m and Vm for f1br1nogen and TAMe 
reveals that there is a difference only in 1m. On the baSis of 
1m, the maximum veloc1ty of reaction 1s attained at a fibrinogen 
concentration which is approximately 3~ of the concentration of 
TAMe on a molar baais. When the reactions are proceeding at maxi-
mum velocity, however, the veloc1ties are the same. 
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The Michaells-Menten equa tlon (3'7) can be wrl tten : 
25. 
where Vo : initial velocity~ 
Po • initial ribrinogen concentration. 
When Po is small compared to Km this equation reduces 
to: 
26. 
That is, the reaction can be represented by a first order equation 
with a rate constant k • Vm/Km. 
Using the above values of 1m and Vm the first order rate 
constant for the proteolysis step is given by 
kl • 7.3/l.9 • 3.8 /min./ml./unit 
This value wl11 hold true only when Fo is small compared 
to Km~ e.g. when Fo 18 10% of Km kl will be 3.5 /mln./ml./unit and 
when Fo il 20, or Km, kl will be 3.2 /min./ml./unit. Also when Fo 
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is higher than say 0.5 Km, significant deviation from first order 
behaviour will be observed. 
2. Determination of a Rate Constant for Step 1. 
With Km and Vm determined it is possible to arrange the 
fibrinogen concentration so that the proteolysis reaction can be 
considered as a first order reaction with a rate constant equal to 
VmJKm. It 1s necessary to study the system under these conditions 
so that from a knowledge of the rate constant the amount of fibrin 
monomer produced at any time can be calculated and comparisons be-
tween steps 1, 2 and 3 can be made. 
To verify that the system follows first order kinetics 
up to about 0.5 mg. fibrillo~en/ml. (i.e. 1'0 • 0.25 Km) more ex-
periments were carried out using the TAMe inhibition method. Ini-
tial fibrinogen concentrations (Po> of 0.5 mg./ml. or less and 
thrombin concentrations up to 0.5 u/ml. were used. The reaction 
was initiated by the addition of thrombin and then stopped atter 
var10us intervals of t1me by the addit10n of TAMe. The amount ot 
fibrinogen remaining at time t ('t) was determined from the ab-
sorbance at 290 lip. of the supernatant. The data t'rom theae ex-
periments 1s shown in Table A-6 of the appendix. Examination of 
this data indicates that, in cases where relat1vely high thrombin 
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concentrations were used the values of Ft reached a minimum value 
which was greater than expected on the basis of the non-clottable 
protein (HC) value. .rig. XVIII shows plots ot' log ('oI't) against 
time where such etfecta were observed. Wlth regard to 'ig. XVIII 
it should be noted that the origin is an experimental point and 
that the reaction is complete after about 1 minute (about ao~ con-
veraion)~ i.e. there i8 no turther increase in log 'oI't atter 1 
minute. Under these conditions therefore only the experimental 
pOints up to about Bo~ conversion can be used to determine a rate 
constant. The dltference between the above minimum value ot 't 
and the non-clottable value could be due to the tact that in the 
TAMe inhibition method, TAMe is a.dded during the early stages ot 
the reaction when the amount of clot tormed 1s much less than max-
imum whereas in the NC determinat10n TAMe 1s added to the reaction 
mixture 3 hours atter the thrombin, when the clot is fully tormed, 
i.e. in the stopped reaction, polymerization takes place in the 
presence of TAfite. There are two posaibill ties 1) TAMe attects the 
polymerization so that conversion ot monomer to clot is leaa than 
in the system where TAMe 1a added atter the clot is tully tormed. 
2) TAMe attecta the equilibrium between clot and intermediate pol-
ymer, implying that a higher value tor NC would be obtained if 
clot were left in contact with TAMe tor a longer period ot time 
than the normal II hours. This second possibility was checked by 
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Pig. XVIII. Determination of a first order rate constant for 
the oonversion of fibrinogen into fibrin monomer. 
o Initial fibrinogen 0.14 OD-290, 0.375 u/ml thrombin • 
• Initial fibrinogen 0.48 OD-2g0, 0.300 u/m1 thrombin. 
N.B. 1) The origin i8 an experimental pOint, 2) After about 
1 minute there is no further increase in log 701Ft i.e. 
the reaction is complete, 3) The value of Pt when log 
PoIPt i8 constant 1s the max-MC value. 
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determining the Ne by adding TAMe 3 houra after thrombin addition 
and then meaauring the OD-2g0 of the supernatant after clot had 
been in equilibrium with TAMe tor 93 hours. The data of Table IX 
show the results obtained in this experiment. The OD-290 was the 
same after 17 hours and after 93 hours thus ruling out the possi-
bility that in the Ne determination a higher He value would have 
been obtained if longer equilibration times had been used. 
It has been shown 1n the determination of Km that more 
cona1atent results are obtained if a correction for He is made to 
't- That the NC 1s different depend1ng on the preaence or absence 
of TAMe and on the point at which TAMe is added alao pOints to the 
fact that 80me correction to 't to allow for non-clottables i. 
neces.ary. A. a consequence three d1fferent values of 't were 
used 1n the fo1low1ng determination of the rate constant, 1) the 
experimental value of 't' oorrected only for TAMe ab80rption and 
dilution (i.e. 1e8s blank) 2) exper1menta1 't (leas blank) 1es. 
the value of HC and 3) experimental 't (leaa blank) 1es8 the min1-
mum value of 't reached for any particular initial fibrinogen oon-
centration. Thia latter correction, which will be called max-Ne, 
waa estimated from the data ot Table A-6 and is shown in Table X. 
The NC value. are shown for comparison. 
TABLE IX 
EPPICT OF EQUILIBRATION TIME ON NOH-CLOTTABLIS 
IN TIm PRESINCI or TAMe 
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Initial ribrinogen * Supernatant OD-290 after 
17 hours 93 hours 
0.68 0.026 0.031 
0.032 0.026 
0.35 0.021 0.022 
0.023 0.025 
0.17 0.012 0.014 
0.013 0.013 
* Corrected for TAMS absorption and dilution. 
0.48 
0.24 
0.14 
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TABLE X 
MAXIMUM CORRECTION FOR NON-CLOTTABLBS 
. 
Max-HC (OD-290) As % of Foo 
0.100 21 
0.045 
0.030 
19 
21 
0.038 8.0 
0.025 10.0 
0.020 14.0 
Table A-'r shows the values of experimental Ft, Pt cor-
rected for NC and Ft corrected for max-NCo 
The value of the first order rate constant was deter-
mined as follows. Under the conditions used in these experimenta 
the reaction ia assumed to be first order with respect to both fi-
brinogen and thromb1n. 
velocity • -dF/dt • klTF 
27. 
Values of klT were calculated by plott1ng log (PoI't) 
against time (mins). The slope of the straight lines 18 then 
equal to kl T/2.3. Table XI ahows the results obtained from these 
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TABLE XI 
VALUES OF k1 T 
(HO CORRiCTION FOR INACTIVATION OF THROMBIN) 
1'0 Thrombin k1T uain& 
OD-290 T. u/m1. 't Ft(NC) lPt(max ... NC) .. 
0.48 0.500 1.93 2.75 4.0 
0.24 0.500 2.37 3.10 4.3 
0.14 0.375 1.79 2.77 3.25 
0.48 0.300 1.1'7 1.41 2.46 
0.24 0.300 1.63 1.95 3.47 
0.48 0.150 0.39 0.50 0.86 
0.24 0.150 0.56 0.'77 1.0'{ 
0.14 0.150 0.78 1.12 1.52 
0.48 0.075 0.15 0.19 0.26 
0.24 0.075 0.24 0.33 0.44 
0.14 0.075 0.29 0.41 0.53 
0.14 O.Oll 0.11 0.17 0.18 
0.35 0.230 0.84 1.09 1.5'{ 
0.41 0.123 0.36 0.50 0.83 
0.2rr 0.123 0.34 0.55 o. rr4 
experlment. and rJ.l&- XIX ahows a plot of klT aSalnst T tor the 
var1ou. flbrlnoasen concentrations used. Thl. fl~ure 1. tor kl T 
calculated using the He correction. Altho~h the value. ot KIT 
are dltterent dependlng on whether experimental Ft , He corrected 
't or max-Ne corrected 't value. are u.ed, the .... type of ourve 
18 obtained aa can be a •• n trom the results shown in Table XI, ex-
cept that the alope ot the 11ne chall&... It 1s alao s.en that, 
tor a sivan th.rombin concentration ... the value ot KIT dependa some-
What on the lnltlal flbrlnosen conoentration ('0). Slnee, tor a 
first order reactlon, kIT should be lndependent of '0 (because the 
ratio 'oIFt determine. the slope) the reactIon 18 apparentl, not 
first order with re.pect to the lnltlal tIbrlno~en concentratIon. 
However, the atralsht 11nea or Fl~. XIX.. when extrapo-
lated, have a positive intercept on the thrombin axi.. One posal-
ble explanation ot this 1s that there 18 InactivatIon of thrombin 
by flbrlnosen and that the extent of this inactivation depend. on 
the fibrInogen concentration. The extent of thrombIn inaotivation 
1. ,iven by the value of the thrombin concentrat.l..ou at the inter-
ce .. t (Kl '1' • 0). The thrombIn concentratIon. at th.a. intercepta 
1. the same resardl... of the non-olottsble correction made to 't 
and are 8holtn 1n Table XII. Tilt'S. result. indicate that the 
amount of thrombin Inactivated appears to va~' proportIonately 
......,. 
~ 0 
en 3.0 
... 
°c • 
:J 
X 
-I 
c: 2.0 E 
-
I--
~ 1.0 
0.2 0.4 
THROMBIN (units/mI.) 
Plg. XIX. Plot of the flrst order rate oonstant (klT) 
aga1nst thrombin concentration. Results cor-
rected for non-clottables. 
• Inltlal fibrinogen 0.14 OD-290 
o Initlal fibrlnogen 0.24 OD-290 
x Initial fibrinogen 0.48 OD-290 
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TABLE XII 
THE INACTIVATION OF THROMBIN BY J'IBRINOOBN 
Fo (OD-290) 
0.14 
0.24 
0.48 
Thrombin Inactivation 
u/m1. 
0.01 
0.02 
0.04 
94 
u/m1·/po 
0.07 
0.06 
0.08 
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with fibrinogen concentration (0.07 units inactivated per 1.0 ab-
sorbance at 290 m~). 
The values of klT from Table XI were corrected for 
thrombin inactivation by multiplying each klT by the factor 
T/(T - I) where T is the total thrombin concentration and I is the 
assumed thrombin inact1vation from Table XII. The results are 
shown 1n Table XlII and Fig. XX is a plot of klT versus thrombin 
corrected for inactivation. The laat three lines of Table XIII 
ahow results calculated from some of the data used to estimate xm 
(Table A4). The only data used was that in which an estimate of 
the extent of thrombin inaotivation could be made from Table XIII 
i.e. where Po was 0.48 OD-290 or less. These results fit very 
well with the other data. Prom these data it is seen that irre-
spective of the non-clottable correction made to Pt~ klT is a 
linear function of thrombin concentration and that the reaction is 
first order with respect to fibrinogen concentration. 
Although the reaction is firat order with reapect to 
~oth thrombin and fibrinogen the value of kl dependa on the cor-
~ection made to Ft. These values together with the standard devi-
~tiona (a) are: 
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TABLE XIII 
VALUES OF kIT 
(CORRECTED FOR THROMBIN INACTIVATION) 
Fo Thrombin 
OD-290 Total u/ml. Correoted u/ml. 
kIT us1ng 
Ft Ft(NC) 't (max-NC) 
0.48 0.500 0.460 2.10 3.00 4.35 
0.24 0.500 0.480 2.47 3.23 4.48 
0.14 0.3'{5 0.365 1.84 2.85 3 .. 34 
0.48 0.300 0.260 1.35 1.63 2.84 
0.24 0.300 0.280 1.75 2.09 3.72 
0.48 0.150 0.110 0.53 0.68 1.17 
0.24 0.150 0.130 0.65 0.89 1.23 
0.14 0.150 0.140 0.83 1.20 1.63 
0.48 0.075 0.035 0.32 0.41 0.56 
0.24 0.075 0.055 0.33 0.45 0.60 
0.14 0.075 0.065 0.33 0.47 0.61 
0.14 0.037 0.027 0.15 0.23 0.25 
0.35 0.230 0.200 0.97 1.25 1.80 
0.41 0.123 0.090 0.49 0.68 1.13 
0.2'7 0.123 0.100 0.42 0.68 0.91 
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Pig. XX. Plots of the first order rate constant (klT) 
versus thrombin concentration corrected for inactivation • 
• Initial fibrinogen 0.48 OD-290 0 Initial fibrinogen 0.24 OD-290 
x Initial fibrinogen 0.14 OD-290 4 Prom ~ data. 
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Ex.perimental: kl • 5.4 /mln/ml/un1t s • 1.14 
HC corrected: kl :a 7.3/mln/ml/un1t a • 1.30 
max-HC corrected: kl • 10.6 /min/ml/unit IS • 1.80 
Vm/Km kl • 3.8 /m1n/ml/unit 8 • 0.6'7 
If it i8 assumed that there is inactivation of thrombin 
by fibrinogen then the difference between the value of kl from 
Vm/Km and that obtained from experiment. specifically designed to 
measure kl i. explained. It 18 seen from Fig. XX, that appropri-
ate Km data, when corrected for thrombin inactivation, fit very 
well with the other data of this figure and therefore thrombin in-
activation can be a.sumed to explain the apparent difference in 
reaction velocity. 
Assuming that kl and xm calculated from Ft corrected for 
non-clottable. are the moat reliable values, the most reliable 
value of Vm will be given by 
Aasuming the molecular weight of fibrinogen 1s 340,000, V • 0.04 
II 
JlM/min/un1 t • 
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3. E!per1ments on the Overall Reaction 
The course of the overall reaction (p clot) was follow-
ed by means of opacity measurements at 310 mu. , to obtain the ex-
perlmental parameters VOl V and tc (Chapter III). The correla-
tions between VOl V, to' flDrinogen and thrombin concentrations 
were explored. Fibrinogen and thrombin solutions of the same con-
centration used to obtain the rate constant kl were used to obtain 
values of VOl V and tc from the clotting curves. These results 
are shown in Table XIV. Fig. XXI shows the result of plotting Vo 
and V against thrombin concentration and Flg. XXII Vo and V 
agalnst fibrinogen concentration. 
Pig. XXI shows that as the thrombin concentration is in-
creased, the arbitrary rate parameters Vo and V at first increase 
and then reach a maximum. The rate of polymerization depends on 
fibrin monomer concentration, and therefore at low thrombin con-
centrations the production of fibrin monomer will be rate limiting 
and the rate of polymerization will increase with thrombin concen-
tration. At high thrombin concentrations with high rates of fi-
br1n monomer production the rate of polymerization will be rate 
determining and consequently a maximum will be observed. 
Since this data was obtained under oonditions where the 
proteolysis step is first order 1n thrombin, the implication is 
TABLE XIV 
.. 
VALUES OF V 0' V AND t c 
ThrombIn u/ml. 
Total Corrected 
0.48 0.075 0.035 1.66 0.304 
0.48 0.150 0.110 0.88 0.475 
0.48 0.300 0.260 0.75 0.608 
0.27 0.120 0.100 1.13 0.220 
0.2,{ 0.300 0.280 0.55 0.312 
0.24 0.0"5 0.055 1.44 0.138 
0.24 0.150 0.130 0.85 0.222 
0.24 0.300 0.280 0.68 0.298 
0.14 0.03'7 0.027 3.25 0.045 
0.14 0.075 0.065 1.85 0.062 
0.14 0.150 0.140 1.37 0.088 
0.14 0.375 0.365 0.70 0.082 
100 
v 
OD-290!mln. 
0.094 
0.164 
0.200 
0.064 
0.130 
0.046 
0.0,{8 
0.096 
0.013 
0.020 
0.028 
0.040 
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Pig. XXI. Plots of the arbitrary rate parameters Vo and 
V against thrombin concentration (corrected 
tor inactivation). 
0,6 
0. 4 
c: 
E 0.2 
" o
(J') 
C\.I 
I 
o 
o 
0.2 
102 
v 
0.1 0.2 0.3 0.4 
INITIAL FIBRINOGEN (00-290) 
F1g. XXII. Plots of the arbitrary rate parameters Vo and 
V against initial fibrinogen concentration. 
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that the polymerization step 1s the slower rate determining step 
in the overall conversion of fibrinogen to clot at pH 7.~~ 
-
-
0.15. Beoause of the arbitrary nature of Vo and V no estimation 
of the polymerization rate constant has, as yet been possible. 
This data is however consistent with that of Mihalyi (Chapter II), 
where it was shown that at pH 7.4, polymerization is slower than 
proteolysis. 
FiS. XXII shows that, up to a thrombin conoentration of 
0.3 u/ml, as the in1tial fibrinogen concentration (Fo) is in-
creased, Vo and V increase in a linear manner. The curves extrap-
olate back to a positive Fo value of 0.08 OD-290 where presumably 
the rate of clot formation is zero, i.e. no clot forms. This im-
plies that a certain amount of fibrin monomer and/or intermediate 
polymer has to be present before olot will form and i8 another in-
dication that some, if not all of the non-clottables should be 
considered as fibrin monomer and intermed1ate polymer in equilib-
rium with clot. 
CHAPTER V 
DISCUSSION 
In order to simplify a theoretical treatment~ the over-
all process can be conveniently represented as: 
T 
F ~ f 28. 
klT 
nr ·f 29. 
~ c 
Where F • fibr1nogen, T • thrombin, f • fibrin mo-
nomer, fa • fibr1n polymer l klT • pseudo f1rst order rate con-
atant l k2 • a rate constant assumed to be f1rst order 1n fibrin 
monomer. In the following treatment, the letters PI T~ fc and f 
w1ll be taken to mean oonoentrat1ons. The notation exp(x) is used 
for eX. 
The assumpt10n that k2 is first order is supported by 
the observations of Mihalyi and Billick (39) reported earlier 
104 
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(Chapter II) in which they determined the rate constants by meas-
uring the hydrogen ions released. 
Rate of disappearance of F 
30. 
Rate of formation ot t 
31. 
Rate of formation ot fc • dfe/dt • k2t 32. 
The rate ot build-up of f • dt/dt • -dF/dt -dtc/dt 33. 
From equations (31), (32) and (33) 
34. 
Integrating equation (34) 
t • 35. 
Substituting equation (35) in equation (32) 
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df~dt • 36. 
IntegratIng equation (36) 
• 37 • 
Prom thIs equatIon, t c , the amount of fIbrIn polymer 
formed at any tIme can be calculated from a knowledge ot the con-
stants '0' kIT, k2 and the tIme t. 
The course of the overall reactIon (p clot) can be fol-
lowed by means of opaclty measurements (Chapter III) and therefore 
the value of fc from equation (37) can be compared dlrectly with 
the amount of clot tormed. 
The opacity-tlme curves and the klnetlc data of Chapter 
IV, corrected for non-clottable proteln, were used to make compar-
Isons between tc and the amount ot clot tormed. UsIng equatIon 
(37) the amount ot tlbrin polymer formed at any tIme (fc) was cal-
culated uslng the approprlate experimental values of klT (trom 
Plg. XIX), '0' T and t and a value of k2 • 2. 
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The total amount of fibrin monomer (t) produoed at any 
time was oalculated from the first order rate equation. 
-dP/dt • k Tt 1 38. 
Pt • FoexP(-klTt) 
and sinoe r • Po - Ft 
• Fo - 'oexp(-klTt} 
r • Po (1 - exp( -kl Tt» 39. 
Fig. XXIII shows typical examples of the experimentally 
determined olotting ourves together with the values of fo and f 
caloulated as shown above. The pOints shown on the fibrin monomer 
curves are the experimental values of ('0 - Ft) uaed to eatimate 
In P1g. XXIII, the clotting time (to) 1a the point at 
whioh the absorbance f1rst starts to increase and Vo i8 the alope 
of the initial sharp increase in opacity. To explore possible 
correlations oetween the variables, the values of to and f at to 
and of Vo were read from F1g. XXIII and Similar curves obtained at 
o 
Q) 
N 
I 
o 
0.1 
0.1 
o 0.1 
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0.037 units thrombin/ml. 
- -- -----> 
---'a 
a --
........ - -b--
, .. 
--
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---
---
0.075 units thrombin Iml. 
----
-----
0.150 units thrombin Iml. 
---
-------
thrombin 1m I. 
2 3 4 5 
TI ME (mins.) 
P1g. XXIII. Experimental and theoretical clotting curves. 
Init1al f1brinogen • 0.14 OD-290. a. total fibrin monomer 
b • total intermediate polymer c • experimental clotting curve. 
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the other fibrinogen and thrombin concentI'ations. These reBul ts 
are shown in Table XV. 
It 18 1mmed1ately apparent from Fig. XXIII that the in-
crease 1n clot opacity cannot be described directly 1n terms of 
the simple model presented here. However, the data of Table XV 
can afford an explanation of the events leading to clot formation. 
P1g. XXIV is a plot of Vo against fibrin monomer (f) at 
to. The two straight lines of this f1gure Join the p01nts where 
the thrombin concentration is a minimum and a maximum respectively 
and can thus be taken as representing l1miting values of Vo for 
the fibrinogen concentrat10ns used. These 11nes extrapolate to 
the monomer axis at f • 0.056 and 0.070 mg./ml. (0.065 and O.oao 
OD-290). This range can therefore be taken to represent the oon-
oentrat10n of f that must be present before clot oan form, 1.e. 
below f • 0.07 mg./ml., Vo i8 zero and therefore no clot forms. 
Pig. XXII of Chapter IV shows a plot of Vo against Fo. 
The stra1ght linea of thl. plot extrapolate to the Fo ax1s at Fo 
• 0.07 mg./ml. (0.08 OD-290) and sim1larly, this can be taken as 
representing the conoentration of fibrinogen that must be present 
before clot can torm. 
Table XV shows that the value of to at to is constant at 
about 0.07 mg./ml. (0.08 OD-290) whlch, as before, can be taken as 
'0 
OD-290 
0.48 
0.48 
0.48 
0.27 
0.27 
0.24 
0.24 
0.24 
0.14 
0.14 
0.14 
0.14 
Thrombin 
u/m1. 
0.300 
0.150 
0.075 
0.300 
0.120 
0.300 
0.150 
0.075 
0.375 
0.150 
0.075 
0.03'7 
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TABLE XV 
CLOTTING PARAlUTERS 
f (Monomer) Vo 
at to OD-290/min. 
0.14 0.21 0.608 1.66 
0.10 0.16 0.475 0.88 
0.10 0.14 0.304 0.75 
0.06 0.16 0.312 1.13 
0.07 0.12 0.22 0.55 
0.08 0.17 0.298 1.44 
0.0'7 0.11 0.222 0.85 
0.06 0.09 0.138 0.68 
0.07 0.12 0.082 3.25 
0.08 0.11 0.088 1.85 
0.07 0.08 0.062 1.37 
0.06 0.07 0.045 0.70 
0.6 
"'" 0.4 c 
E 
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0 
en 
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• 
Pig. XXIV. Plot of Vo against total fibrin monomer at the 
olotting time. Curve A, minimum thrombin concentration used, 
curve B, maximum thrombin concentration used. x , Initial fi-
brinogen 0.14 OD-290, 0 J Initial fibrinogen 0.24 OD-290,o ini-
tial fibrinogen 0.27 OD-290, • initial fibrinogen 0 .• 48 OD-290. 
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representing the concentration of !'a that must be present before 
clot can form. 
S"llllllllarizing the above findings. 
1) Below a minimum initial fibrinogen concentration of 
0.07 mg./ml~ clot formation is infinitely slow i.e. no clot forms, 
(Pig. XXII). 
2) Before a clot ean form, the total amount of flbrin 
monomer produced has to be at least 0.07 mg./ml, (Fig. XXIV). 
3) A clot will form only when fc 1s at least 0.07 mg./ 
ml, ('fable XV). 
Taking tc to represent some lntermediate polymer, it is 
postulated that when the concentration of fc reaohes 0.07 mg./ml. 
insoluble polymer (i.e. clot) starts to form. This 1dea i8 sup-
ported by the findings that no clot can form unless a concentra-
tion of 0.07 mg./ml. of fibrin monomer is present and that no clot 
can form unless the initial fibrinogen concentration 1s at least 
0.07 mg./ml. That 1s, unless the in1tial fibrinogen conoentration 
is at least 0.07 mg./ml.} flbrin monomer concentration cannot pos-
sibly reach 0.07 mg./ml. and fc concentration cannot possibly 
reaoh 0.0'7 mg. /ml. 
Clot formation can therefore be postulated to proceed as 
tollows. fibrinogen 1s converted into fibrin monomer and this 
then polymerizes to intermediate polymer. At a critical degree of 
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polymerization, represented by fc • 0.07 mg./ml., the polymeri-
zation of a relatively· few extra monomers onto each intermediate 
polymer results in visible clot formation. Just prior to tc there 
is a high concentration of critically sized intermediate polymer. 
At tc the addition of a relatively few monomers onto intermediate 
polymer results in clot formation and therefore at tc~ clot forma-
tion will be rapid as is actually observed (rig. XXIII). After 
this initial rapid increase in clot formation, fc concentration 
will be low and clot formation will be limited by the rate of 
polymerization of fibrin monomer whioh in turn depends on fibrin 
monomer conoentration. After the initial sharp increase, clot 
formation should therefore parallel fibrin monomer, or fC I produc-
tion as is actually observed (Pig. XXIII). 
Although the oritical monomer, intermediate polymer con-
centration at tc is 0.07 mg./ml., the value of the non-clottables 
is less than thiS. The value of 0.07 mg./ml. is the concentration 
of intermediate polymer that must be reaohed before clot starts to 
form whereas the non-olottable is the final concentration of mo-
nomer and/or polymer in equilibrium with the clot. The equilib-
rium between monomer, intermediate polymer and clot will favor 
clot because clot is removed trom solution and the equilibrium 
will theref.ore be displaced 1n this direction. 
SUMMARY 
The fibr1nogen-fibrin conversion can be represented 
as: 
Step 1. Proteolysis 
Step 2. Polymerization 
Step 3. Clott1ng 
F--.... f 
nf --.. ~ f 
n 
-~ .. (fn)m 
Where' • fibrinogen, f • fibrin monomer and T • thrombin. 
By using TAMe as a thrombin inhibitor, step 1 can be 
isolated and studied as a proteolytic reaction. When fibrinogen 
is converted into a fibrin clot, 80me protein material, the non-
clottables, always remains in solution. The assumption is made 
that this material is fibrin monomer and/or polymer in equilibrium 
with the clot and should therefore be considered as product ln the 
reactlon. Making correctlons for the non-clottables, the 
Michaells-Manten constant Km and the maximum velocity Vm, of the 
reactlon were determined and are: 
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K • 5.6 uM (1.9 mg/ml) 
m 
V • 0.02 uM/min/llnlt (1.3 mg/min/unit) 
m 
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Data are presented which show that, up to an initial fi-
brinogen concentration of 0.4 mg/ml and thrombin concentrations 
from 0.037 to 0.5 u/ml., thrombin is inactivated by fibrinogen 
(0.06 u/ml/mg fibrinogen). If thrombin inactivation is taken into 
account, the reaction is shown to be first order with respect to 
thrombin and fibr1nogen up to a fibr1nogen concentrat1on of 0.4 
ma/ml (i.e. Fo • 0.2 'm). The value of the f1rst order rate 
constant, kl' depends on whether or not corrections are applied 
for the effect of non-clottable material. Assum1ng that non-clot-
table prote1n is react10n product the value of th1s rate constant 
is 7.3jmin/un1t. The d1fference between this value and the value 
of kl • V~m • 3.8/min/unit 1s explained by thrombin 1nact1v-
at1on. 
The course of the overall reaction (F~clot) was fol-
lowed by means ot opac1ty measurements at 310 mu. Opacity-time 
recordings show a lag period (the clotting time t c )' an initial 
sharp increase in OD-3l0 (Vo) and then a slower increase in 0D-310 
Also, an attempt was made to explain the events leading to the 
production ot a fibrin clot by means of a model in which step 1 
and step 2 are assumed to be two first order consecutive reactions. 
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In terms of this model, the amount of polymer produced at any time 
(fc) is given by an equation of the :form" 
Where kl and k2 are the rate constants for proteolysis and poly-
merization and T i8 the thrombin concentration. 
Correlations between the values of Vo derived from the 
opacity-time reoordings, the value of the total fibrin monomer 
produoed (from the step 1 rate experiments), the values ot fo ob-
tained from the above equation and initial fibrinogen and thrombin 
concentrations were explored. Sufficient correlation was observed 
between these parameters to postulate clot formation as proceeding 
as tollows. Pibrinoaen is converted into fibrin monomer and this 
then polymerizes to intermediate polymer. At a critical dearee ot 
polymerization, represented by fo • 0.07 mg./ml., the polymeri-
zation ot a relatively tew extra monomers onto each intermediate 
polymer results in visible clot tormation. Just pr10r to tc there 
is a high concentration of critically sized intermediate polymer. 
At tc the addition ot a relatively tew monomers onto intermediate 
polymer re8ults in clot formation and therefore at t c, clot forma-
ll'{ 
tion will be rapid as is ll.ctually observed. After thisini tial 
rapid inorease in clot formation J fc concentration will be low and 
clot formation will be limited by the rate of polymerization of 
fibrin monomer which in turn depends on fibrin monomer ooncentra-
tion. After the initial sharp inorease, clot formation should 
therefore parallel fibrin monomer, or fc' production as 1s aotual-
131' observed. 
Although the critical monomer, intermediate polymer oon-
centration at tc is 0.0'7 mg./ml ... the value of the non-olottables 
is less than this. The value of 0.0'7 mg./ml. is the ooncentration 
ot intermediate polymer that must be reached before clot starts to 
form whereas the non-olottable is the final concentration ot mo-
nomer and/or polymer in equilibrium with the clot. The equilib-
rium between monomer, intermediate ,Polymer and clot will favor 
olot because clot i8 removed from solution and the equilibrium 
will therefore be displaoed in this direction. 
APPBllDIX 
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TABLE Al 
D~NATION OF CLOTTING ACTIVITY BY THE BIH CLOTTIBO METHOD 
Titrat10n Mix. 
ml. 
3 
3 
3 
3 
3 
3 
3 
Thrombin 
ml. 
0.6 
0.5 
0.4 
0.3 
0.2 
0.15 
0.1 
Saline 
ml. 
0.4 
0.5 
0.6 
0.7 
0.8 
0.6S 
0.9 
Thromb1n Clott1ng T1me 
Clott1ng seconds * 
units/ml. 
1.5 10.6 -0.1 
1.25 11.1 -0.4 
1.0 17.0 -0.5 
0.'75 19.3 -0.4 
0.5 23.7 -0.8 
0.315 36.1 -0.3 
0.25 54. '7 -1.4 
* Average of 3 determinatIons. 
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TABLE A2 
HYDROLYSIS OJ' TAMe BY THROMBIJf 
Thrombin TAMe Initial Velocity ( OD-2~7/min)-1 (M.TAMe)-l 
JIIxlO~ OD-24'7/min. 
Parke- 19.40 0.0380 26.3 513 
Davia 9.70 0.0370 27.0 1030 
3.5 u/ml. 6.50 0.0330 30.3 1540 
4.80 0.0290 34.5 2060 
3.20 0.0270 3'7.0 3130 
1.94 0.0230 43.5 5130 
0.97 0.0145 69.0 10300 
Fraction 14.80 0.0215 46.6 675 
7. 7.40 0.0180 55.5 1350 
Table VI 2.48 0.0140 71.5 4040 
2.0 u/m1. 1.64 0.0115 8'7.0 6100 
1.48 0.0110 91.0 6'750 
TABLE A3 
EJ'lPl£CT 0' TAMe ON NOH-CLOTTABLES 
Fibrinogen 
* Original OD-290 
0.036 M TAMe in Butter 
-
0.613 
1.23 
2.46 
4.91 
0.036 ! KC1 in Butter 
0.355 
0.676 
1.49 
2.13 
3.89 
Butter only 
0.355 
0 .. 613 
1.23 
2.46 
4.91 
Clot Removed 
OD-290* 
0.050,,0.053 
0.084,,0.095 
0.163,,0.172 
0.335,,0.315 
0.030 .. 0.035 
0.039,,0.040 
0.078,,0.084 
0.111 .. 0.115 
0.202 .. 0.200 
0.034 
0.045 .. 0.050 
0.065,,0.069 
0.118,0.127 
0.210 
Average 
0.052 
0.090 
0.168 
0.325 
0.033 
0.039 
0.081 
0.113 
0.201 
0.034 
0.048 
0.067 
0.123 
0.210 
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** Corrected 
0D-290 
0.032 
0.074 
0.160 
0.332 
0.036 
0.043 
0.089 
0.124 
0.220 
* Correoted tor Tria-Acetate Blank Absorption. 
** Corrected tor TAMe Absorbance and Dilution. 
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TABLE A4 
INITIAL VELOCITIES OF THE PBOTEOLYSIS REACTION 
Reaction Initial Clot (J'o ... Ft) (po·J't) 
Time F1br1n?men Supernatant 
t mina 1'0 mg 181 Ft .g/ml m&/ml t 
Thrombin - 0.123 u/ml. 
0.5 0.235 0.207 0.028 0.056 
1.0 0.235 0.151 0.084 0.084 
0.5 0.357 0.306 0.051 0.102 
1.0 0.357 0.235 0.122 0.122 
0.5 0.623 0.551 0.072 0.144 
1.0 0.623 0.425 0.198 0.198 
0.5 1.235 1.145 0.090 0.180 
1.0 1.235 0.937 0.298 0.298 
Thromb1n - 0.230 u/m1. 
0.5 0.308 0.199 0.109 0.218 
1.0 0.308 0.136 0.172 0.172 
0.5 0.587 0.426 0.161 0.322 
1.0 0.587 0.282 0.305 0.305 
0.5 1.290 1.030 0.260 0.520 
1.0 1.290 0.773 0.517 0.517 0.5 1.850 1.520 0.330 0.660 
1.0 1.850 1.270 0.580 0.580 
Thromb1n - 0.50 ujm1. 
0.5 0.205 0.062 0.143 0.286 0.5 0.410 0.137 0.273 0.546 
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VALUES 0' l/v 0 AND Ijr 0 POR LlHEWEA YER-BURKE PLOT 
Thrombin C'o-Ft) (Po-Ft) (1'0)-1 (JPo-'t) -1 Reaction '0 t 
Time min •• g/ml T. u/ml. m&Lml/min t. T t. T 
0.5 0.235 0.123 0.098 0.80 4.25 1.25 
1.0 0.235 ft 0.105 0.85 4.25 1.18 
0.5 0.357 n 0.158, 1.28 2.80 0.78 
1.0 0.35'7 " 0.150 1.22 2.80 0.82 
0.5 0.623 It 0.236 1.92 1.61 0.52 
1.0 0.623 If 0.244 1.g8 1.61 0.51 
0.5 1.235 It 0.352 2.86 0.81 0.35 
1.0 1.235 It 0.374 3.04 0.81 0.3'7 
0.5 0.308 0.230 0.2,{0 1.1'7 3.24 0.85 
1.0 0.308 n 0.lg8 0.86 3.24 1.15 
0.5 0.587 " 0.408 1.77 1.70 0.56 
1.0 0.587 .. 0.348 1.51 1.'70 0.66 
0.5 1.290 " 0.684 2.97 O.T! 0.34 
1.0 1.290 " 0.599 2.61 0.77 0.38 
0.5 1.8SO tt 0.914 3.g8 0.54 0.25 
1.0 1.850 " 0.707 3.08 0.54 0.32 
0.5 0.205 0.5 0.330 0.660 4 .. 86 1.52 
0.5 0.410 0.5 0.616 1.232 2.44 0.82 
TABLE A6-1 
DETERMINATION or kl VALUBS 0' Ji't 
Initial Fibr1nogen Concentration - 0.48 OD-290 
Non-clottables 
Max-NC 
Thrombin 0.30 u/ml. 
Reaction T1me mina. 
Ji't OD-290 
J't (NC) OD-290 
J't (max-NO) OD-290 
Thrombin 0.15 u/ml. 
Reaction Time mina. 
Ji't OD-290 
Ji't (Ne) OD-290 
't (max-NO) OD-290 
Thrombin 0.075 u/m1. 
Reaction Time mins. 
't OD-290 
Ft (If C) 0D-290 
J't (max-NC) OD-290 
0.5 
0.244 
0.206 
0.144 
1.0 
0.319 
0.281 
0.219 
2.0 
0.368 
0.330 
0.268 
1.0 
0.154 
0.116 
0.054 
2.0 
0.228 
0.190 
0.128 
4.0 
0.304 
0.266 
0.204 
- 0.038 0D-290 
... 0 .. 100 0D-290 
1.5 2.0 
0.099 0.083 
0.061 0.045 
-
3.0 4.0 
0.135 0.108 
0.097 0.070 
0.035 0.008 
6.0 8.0 
0.170 0.149 
0.132 0.111 
0.0'70 0.049 
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2.5 
0.102 
0.064 
5.0 
0.086 
0.048 
10.0 
0.187 
0.149 
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TABLE A6-2 
DETERMINATION OF k1 VALUES OF Ft 
In1t1a1 P1brinogen Conoentrat1on - 0.24 OD-290 
Bon-e1ottab1ee - 0.025 OD-290 
Max-NC - 0.045 0D-290 
Thrombin 0.30 u/m1. 
Reaction Time mine. 0.5 1.0 1.5 2.0 2.5 
1ft 0D-290 0.105 0.049 0.041 0.059 0.054 
Ft (NC) OD-290 0.080 0.024 0.016 0.034 0.029 
Pt (max-NC) OD-290 0.060 0.004 
Thrombin 0.15 u/ml. 
Reaotion T1me m1na. 1.0 2.0 3.0 4.0 5.0 
Ft OD-290 0.141 0.01'7 0.047 0.041 0.059 
1ft (NC) OD-290 0.116 0.052 0.022 0.016 0.034 
1ft (max-NC) OD-290 0.096 0.022 
Thrombin 0.075 u/ml. 
React10n Time mine. 2.0 4.0 6.0 8 .. 0 10.0 
Pt OD-290 0.151 0.089 0.058 0.059 0.070 
1Pt (Ne) OD-290 0.126 0.064 0.033 0.034 0.045 
Ft (max-NC) OD-290 0.106 0.044 0.013 0.014 
TABLE A6-3 
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DETERMINATION OF k1 VALUES OF Ft 
Initial Fibrinogen Concentration - 0.14 OD-290 
Non-clottables - 0.020 OD-290 
Max-NC - 0.030 OD-290 
Thrombin 0.375 u/ml. 
Reaction Time mins. 0.5 1.0 1.5 2.0 
't OD-290 0.052 0.029 0.036 0.030 
Ft (HC) OD-290 0.032 0.009 0.016 0.010 
Pt (max-NC) OD-290 0.022 0.009 
Thrombin 0.15 u/m1. 
Reaction Time mina. 0.5 1.0 1.5 2.0 
Ft 0D-290 0.161 0.064 0.044 0.029 
't (NC) OD-290 0.141 0.044 0.024 0.009 
Ft (max-NO) OD-290 0.131 0.034 0.014 
Thrombin 0.0'75 u/m1. 
Reaotion T1me mina. 1.0 2.0 3.0 4.0 
't OD-290 0.150 0.081 0.069 0.041 
lPt (NC) OD-290 0.130 0.061 0.049 0.021 
Ft (max-NC) OD-290 0.120 0.051 0.039 0.011 
Thrombin 0.0375 ~/ml. 
Reaction Time mina. 2.0 4.0 6.0 8.0 
lPt OD-290 0.13.5 0.103 0.065 0.056 
't (NC) OD-290 0.115 0.083 0.045 0.036 
Pt (max-NC) OD-290 0.105 0.073 0.035 0.026 
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MISCELLANEOUS MAT~RIALS 
Ammonium Sulfate. (NH4)2S04- granular, pyridine free. Analytical 
Reagent. Malllnckrodt Chemical Works. 
Calcium Chlorlde. O&C12- 2H20, granular. Analytical Reagent_ 
Mallinckrodt Chemical Works. 
Potassium Chloride. KCl granular. Analytlcal Reagent. 
Mallinckrodt Chemical Works. 
Sodium Chloride. HaCl crystals. Analytical Reagent. 
Malllnckrodt Chemical Works. 
Sodium Phosphate. N~HP04. l2H20, orystals. Baker Analyzed 
Reagent. J.T. Baker Chemloal Co. 
Sodium Phosphate. NaH2P04' H2O, crystals. Baker Analyzed 
Reagent. J.T. Baker Chemical Co. 
Tris-acetate: Tris(hydroxymethyl)aminomethane F.W. 121.14. Fisher 
Sclentifio CO.,m.pt. 170.8-171.8°., Lot 731519. 
pH 7.4 Tria-aoetate ionic strength 0.15 was prepared by 
mixing together, 150 mI. 1.0 M aoetlc acid and 177 mI. 1.0 M Trls. 
and making up to 1 liter with distilled water. pH 7.4. 
TAMe: p-tosyl L-arginine methyl ester. F.w. 378.5. Sigma Chemical 
Co. Lot T42B-083; Gallard Schlesinger Mrg. Co., g.s. A2644,m.pt. 
143 - 146°. 
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Both these preparations gave identical rates of hydro-
lysis when hydrolysed by thrombin. 
Thrombin. Fractions 3, 4, 5 and 6 of Table VI were used for clot-
ting studies. Fractions 3, 7 and 8 were used for calibration of 
the clotting and esterase activities of thrombin. 
Fibrinogen. Practions Pl, P2~ P2gel from experiment 1, fractions 
PI, Plgel, P2 and OP2 from experiment 2, Table IV were used indis-
criminately throughout. 
1. 
2. 
3. 
4. 
5. 
6. 
8. 
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ABSTRACT 
The ,fibrinogen-flbrin conversion can be represented 
as: 
T 
Step 1. Proteolyai8 P-----a-f 
Step 2. Polymerization nt'~f' n 
Step 3. Clotting m(1'n) ----.. (rn)m 
Where" • fibrinogen, l' • i ~brln monomer and T • thromb1n. 
By using TAMe as a thrombin inhibitor, step 1 can be 
iaolated and studied a8 a proteolytic reaction. When tlbrinogen 
is converted into a t~brin clot, some protein material, the non-
clottables, always remains in solution. The assumption i8 made 
tl~t thi8 material 18 fibrin monomer and/or polymer in equilibrIum 
with the clot and should therefore be oon81dered as produ.ct in the 
reaction. Making corrections tor the non-clottables, the 
Michael18-Menten constant ~ and the maXimum velocIty V
m
, 01' the 
reactIon were determined and are: 
K 
m 
V 
m 
• 
• 
5.6 uM (1.9 mg/ml) 
0.02 uM/mln/un.:i. t ({. 3 mg/m1n/uni t ) 
Data are presented which show that, up to an initial fi-
brInogen concentration of 0.4 WS/m1 and thrombin concentrations 
from 0.037 to 0.5 u/ml., thromb1n is inactivated by 1'10r1nog8n 
(0.06 u/al/mg fibr1nogen). It thrombin 1nactivation is taken into 
account, the reaction 18 shown to be fIrst order with respect to 
thrombln and. fibrinogen up to a flbrinogen concentration ot 0.4 
mg/ml (i.e. Fo : 0.2 Km). The value of the first order rate 
constant, kl , depends on whether or not corrections are applIed 
tor the effect of non-clotteble material. Assum~ng that non-clot· 
table protein 1s reaction product the value ot this rate constant 
is 1.3/min/unlt. The difterence between trus value and the value 
of kl • VmfKm • 3.8/min/un1t 1s expla1ned by thrombin lnactlv-
ation. 
The course of the overall reaction (F~clot) was fol-
lowed by means of opacity measurements at 310 mu. Opacity-tIme 
recorcilngs show a lag period. (the clotting t1me to)., an lnitial 
sharp lncrease in 01>-310 (Vo ) and then a slower lncrease in OD-31C. 
Also, an attempt was made to explain the events leadlng to the 
productlon of a f1brin clot by means ot a model 1n which step 1 
and step 2 are assumed to be two first Qrder conaecut1ve react1onl~ 
In terms of this model, the amount of polymer produced at any t1me 
(te ) 1s given by an equation of the form, 
Where Kl and k2 are the rate constants tor proteolysis and poly-
merization and T 18 the thrombin concentration. 
Correlations between the values of Vo derived trom the 
opacity-time recordings, the value of the total fibrin monomer 
produced (from the step 1 rate exper1ments), the value ot' f c ob-
tained from the above equation and initial fibrinogen and thrombin 
concentrations were explored. Sufficient correlat1on was observed 
between these parameters to postulate elot formation as proceed1nS 
as tollows. FIbrinogen 1s converted into fibrin monomer and thls 
then polymerizes to intermedIate polymer. At a crit1cal degree ot 
polymerization, represented oy 1"c = O.O'{ mg./ml., the polymeri-
zation ot' a relat1vely few extra monomers onto each 1ntermecUate 
polymer results in visible clot formation. Just prIor to tc there 
1s a h1gh concentration 01' critically sized intermed1ate polymer. 
At tc the addition of a relatlvely tew monomers onto intermediate 
polymer resulta in clot format1on and ther~tore at tel clot forma-
tion will be rapid aa 1s actually observed. Atter this initial 
rap1d increase 1n clot formatlorl J fc concentration will be low and 
clot formation wl11 be limited by the rate of polymerization of 
Ciot'in monomer whlch in turn depends on fibrin monomer concentra-
tion. After the initial sharp increase, clot formation should 
therefore parallel fibrin monomer, or f c ' production as 1s actual-
ly observed. 
AltholAsn tne crlt1cal monomer;, .1.ntermed1ate polymer con-
centrat10n at tc is 0.07 rag./ml., the value of the non-clottables 
1s leB8 than th18. The value of' 0.0'7 rag./ml. i8 the concentration 
of intermediate polymer that must be reached before clot starts to 
form whereas the non-clottable i8 the final concentration of mo-
nomer and/or polymer in equilibrium with the clot. The equl11b-
ri.ur& between monomer, intermediate polymer and clot will favor 
clot because clot 1s removed from solution and the equilibr1um 
will the ref' ore be d1splaced in this direction. 
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